Time

Track 1

Track 2

Track 3

Track 4

Day 1-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 1-8:00 AM


Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words
Track 1 Broadcast: Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words

Day 1-8:15 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients

Day 1-8:30 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Continued
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Continued

Company Competition Semi-Finals


Andrew Kurtz, NCI SBIR
Day 1-Sessions:

Immunotherapy: Emerging Applications and Therapies

Enabling Clinical-Grade NGS Testing

Company Competition Semi-Finals Continued

Day 1-8:45 AM

James Allison, MD Anderson Cancer Center
Opening Words by Session Chair
Sean Scott, Qiagen
Enabling Clinical-Grade NGS Testing “Dry Lab” Capabilities in Oncology
Abogen

Day 1-9:00 AM

Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immuno-oncology
Personalized Medicine - The Cinderella Story of Venture Investments?
Mara Aspinall, Genepeeks
Opening Words by Session Chair
Accelerated Medical Diagnostics

Day 1-9:15 AM

Debbie Law, Jounce Therapeutics
Developing JTX-2011 ICOS Agonist: A Translational Approach
Alexis Borisy, Third Rock Ventures
AccuraGen

Day 1-9:30 AM

James H. Godsey, Thermo Fisher Scientific
Addressing Immuno-oncology Research Challenges for Predictive Biomarkers
Andrew J. Schwab, 5AM Ventures
biomaRx

Day 1-9:45 AM

Q&A
Lindy Morris Fishburne, Breakout Labs
Cernostics

Day 1-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Issues and Challenges of Immunotherapy

The Value of Data Sharing

Company Competition Semi-Finals Continued

Emerging Infections: Tracking, Testing and Public Health Response

Day 1-10:30 AM

Lawrence Corey, Fred Hutchinson
Opening Words by Session Chair
John Leite, Illumina
John Shon, Illumina
Words by Session Co-Chair
Congenica Ltd.
Steve Miller, UCSF
Opening Words by Session Chair

Day 1-10:45 AM

Steve Harr, Juno Therapeutics
Lincoln Nadauld, Intermountain Healthcare
Sharon Terry, Genetic Alliance
CloudMedx
John Hackett, Abbott Laboratories
Challenges Associated With Development of Diagnostics to Emerging Agents

Day 1-11:00 AM

Ronald A. DePinho, MD Anderson Cancer Center
Juli Klemm, National Cancer Institute
Kathy Giusti, Multiple Myeloma Research Foundation
DName-iTDongxiang Xia, California Depart. of Public Health
Emerging Viral Infections: Lab Response

Day 1-11:15 AM

Crystal L. Mackall, Stanford University
Robert Nussbaum, Invitae
Gritstone Oncology
Q&A
Day 1-Sessions:

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Understanding Human Health and Diseases at the Individual Level

Company Competition Semi-Finals Continued

An Update on the Cancer Moonshot Blood Profiling Atlas

Day 1-11:30 AM

Brad Gray, NanoString Technologies
Opening Words by Session Chair
Euan Ashley, Stanford
Opening Words by Session Chair
Inanovate
Bruce Press, Seven Bridges
Opening Words by Session Chair

Day 1-11:45 AM

Kenneth Emancipator, Merck
Richard Chen, Personalis
Precision Medicine for Immuno-Oncology: Personalized Cancer Vaccines and Diagnostics
Inmedix
Howard I. Scher, Memorial Sloan Kettering Cancer Center

Day 1-12:00 PM

Daniel Chen, Genentech
Jessica Mega, Verily
JBS Science
Geoff Otto, Foundation Medicine

Day 1-12:15 PM

Steven Averbuch, Bristol-Myers Squibb
Sowmi Utiramerur, Stanford Health Care
KIYATEC
Q&A

Day 1-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 1-Sessions:

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Company Competition Semi-Finals Continued

Reaching New Heights in Sequencing

Day 1-1:30 PM

Chris Cournoyer, N-of-One
Opening Words by Session Chair
John Ryals, Metabolon
Metabolomics and Its Role in Precision Medicine
Sequence BioMirna Jarosz, IDT
Methods for Accurate Variant Detection in cfDNA

Day 1-1:45 PM

Donald L. (Skip) Trump, Inova Schar Cancer Institute.
Emily Leproust, Twist Bioscience
Rewriting DNA Synthesis
Standigm
Alexander Bisignano, Phosphorous
A Distributed Clinical Data Network

Day 1-2:00 PM

Thomas D. Brown, Swedish Cancer Institute
Gautam Kollu, Illumina
Diagnosing genetic diseases using Whole Genome Sequencing
Two Pore Guys
Frederick Lee Baehner, Genomic Health
Where Value Based Care and Precision Medicine Converge

Day 1-2:15 PM

Q&A
Summerpal Kahlon, Oracle
Intelligent Care: Translating Data into Insight
Vitatex
Kaja Milanowska, Ardigen SA
Artificial Intelligence for Personalized Medicine
Day 1-Sessions:

Importance of Standardized Assays for Precision Medicine

Clinical Applications of ctDNA in Cancer Management

Emerging Technologies

Learnings from Precision Medicine Centers

Day 1-2:30 PM

Jeffrey Edward Miller, Invivoscribe
Opening Words by Session Chair
Clive Morris, Inivata
The Future of ctDNA
Fabien Beckers, Arterys
Adding Medical Imaging Features to Precision Medicine
Berta Strulovici, The Israel National Center for PM
Integrated Technological Platforms in Israel

Day 1-2:45 PM

Bradley Patay, Genection
Importance of Design Controlled Assays in Hematopathology
Nitzan Rosenfeld, Inivata
Targeted Deep Sequencing of Circulating Tumor DNA
Stephen J. Matlin, Life Length
Telomeres: Unlocking The Aging Code
Mathias Uhlen, SciLifeLab
The SCAPIS SciLifeLab Wellness Profiling Program

Day 1-3:00 PM

Mark Levis, Johns Hopkins University
Acute Myeloid Leukemia: Bringing Order Out of Chaos
Ramaswamy Govindan, Washington University School of Medicine
ctDNA in the Treatment of Lung Cancer- Opportunities and Challenges
Stephen Quake, Stanford University
Precision Measurements in Biology
Vandhana Krishnan, Stanford University
Assessment of Variant Calling Pipelines for Clinical Diagnosis

Day 1-3:15 PM

Q&A
Q&A
Nick Lench, Congenica
Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes
Cuiping Pan, VA Palo Alto
Million Veteran Program Builds a Mega-biobank for Human Disease Research

Day 1-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Leveraging Chip Technologies for Healthcare

Moving Precision Medicine to Precision Health

Podium Presentations

Adoption of Precision Medicine: Hereditary Cancer

Day 1-4:00 PM

Roeland Huys, imecHarold L. Paz, Aetna
Opening Words by Session Chair
Boris Hayete, GNS Healthcare
Parkinson’s Disease: in Search of Predictors of Progression
Taylor Sittler, Color Genomics
Opening Words by Session Chair

Day 1-4:15 PM

Clinical Next-Generation Sequencing for Infectious Disease Diagnosis


Charles Chiu, UCSF
Opening Words by Session Chair
Lincoln Nadauld, Intermountain Healthcare
Paul Docherty, Hologic
Diagnostic: Pharma Relationships in CDx Development
Kevin Hughes, Harvard Medical School

Day 1-4:30 PM

Robert Schlaberg, IDbyDNA Inc.
Dx Application of NGS Tests for Infectious Diseases
Amy Burd, LLS
George Vasmatzis, Mayo Clinic
Detecting Rearrangements Using NGS and Applications to Biomarker Discovery
Theodora Ross, UT Southwestern Medical Center

Day 1-4:45 PM

Heike Sichtig, US Food and Drug Administration
FDA’s Role and Tools for ID-NGS Diagnostics
Harlan Krumholz, Yale School of Medicine
Fred Streitz, Lawrence Livermore National Laboratory
Accelerating Cancer Research with Extreme Scale Computing
Heather Hampel, The Ohio State University Wexner Medical Center

Day 1- 5:00 PM

Mickey Kertesz, Karius, Inc.
Infectious Disease Diagnostics for the Genomic Era

An Update on the Cancer Moonshot and Brain Government Initiatives


Joshua Gordon, National Institute of Mental Health
Update from the NIMH: Precision Medicine and the BRAIN Initiative

Day 1- 5:15 PM

Track 1 Closing for Day 1

Track 2 Closing for Day 1

Track 3 Closing for Day 1Track 4 Closing for Day 1

Time

Track 1

Track 2

Track 3

Track 4

Day 2-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 2-Sessions:

How Scientific Wellness Will Transform Healthcare

An Update on the Cancer Moonshot and Brain Government Initiatives (Cont.)

Day 2-7:30 AM

Lee Hood, Providence Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force
Walking On The Moon: Reflections

Podium Presentations

Peter Donnelly, Oxford University
Learning the Human Wiring Diagram from Genomics

Day 2-7:45 AM

Rodney F. Hochman, Providence St. Joseph Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force- Continued
Walking On The Moon: Reflections
Eric Kowack, Ignyta
An Innovative Approach For Dx-Driven Oncology Trials

Unlocking Real-World Clinical Data


Sean Scott, Qiagen
Integrating NGS-based Test Results with Clinical Outcomes Data to Improve Physician Decision Support
Day 2-Sessions:

How Molecular Subtyping Can Aid Clinical Drug Development

Population Precision Medicine
Presented by India Hook-Barnard

Podium Presentations Continued

Unlocking Real-World Clinical Data continued

Day 2-8:00 AM

Janusz Dutkowski, Data4Cure
Opening Words by Session Chair
Kirsten Bibbins-Domingo, UCSF
Opening Words by Session Chair
Amy Burd, LLS
Introducing a New Concept in AML
Amy Abernethy, Flatiron Health
Opening Words by Session Chair

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:30 AM

How to Commercialize Technologies That Advance PM


Alex De Winter, GE Ventures
Fireside Chat
Robert A. Hiatt, UCSF

Driving Value for Genomics Startups


Amanda Cashin, Illumina Accelerator
George Komatsoulis, CancerLinQ
Big Data in Cancer Care

Day 2-8:45 AM

Mark Fischer-Colbrie, Labcyte
Fireside Chat
Q&A
Trevor Levin, UrologyDx
Nick Conley, Epibiome
Phong Le, HPE
Preparing for the Next Step in Genomic Analysis
Day 2-Sessions:

New Healthcare Paradigm from the $100 Genome

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Enabling Advances in Human Microbiome Research

CIAPM: Accelerating Precision Medicine Advances in California

Day 2-9:00 AM

Yiwu He, BGI
Implications of $100 Whole Genome Sequencing
Assaf Halevy, 2bPrecise
Opening Words by Session Chair
Nick Conley, Epibiome
Opening Words by Session Chair
Elizabeth Baca, Governor's Office of Planning and Research
Opening Words by Session Chair

Day 2-9:15 AM

Q&A
Holli Hutcheson Dilks, Sarah Cannon Research InstituteDavid Mills, UC Davis
Restoring Ecosystem Function in the Infant Microbiome
Uta Grieshammer, CIAPM

Day 2-9:30 AM

Rade Drmanac, Complete Genomics, Inc. (a BGI company)
Efficient WGS as Foundation for Precision Medicine
John Mattison, Kaiser PermanenteSusan Lynch, Siolta Therapeutics
The Gut Microbiome and Childhood Allergic Asthma
Nicholas Anderson, UC Davis
Rowan Chapman, Johnson & Johnson Innovation - California

Day 2- 9:45 AM

Q&A
Amy Urban, UPMC
Joel Diamond, 2bPrecise
Lihi Segal , DayTwo
Personalized Nutrition Using Gut Microbiome and Clinical Data
Brennan Spiegel, Cedars-Sinai
Olena Morozova, UCSC

Day 2-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

How To Engage Community Oncologists in Precision Medicine

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Emerging Themes in the Human Microbiome

Data Sharing: Patient Rights and Privacy

Day 2-10:30 AM

Lincoln Nadauld, Intermountain Healthcare
Laurence Marton, PMWC 2014 Session Chair
Words by Session Co-Chair
Atul Butte, UCSF
Driving Disease Understanding and Treatment via a Centralized Data Warehouse
Michael Fischbach, California Institute for Quantitative Biosciences (QB3)
Opening Words by Session Chair
William Knox Carey, Genecloud
Opening Words by Session Chair

Day 2-10:45 AM

Tim Collins, Scripps Health
Diane Wuest, GNS Healthcare
Unlocking Precise Knowledge within Complex Data via Causal Machine Learning
Erica Sonnenburg, Stanford University School of Medicine
Sharon Terry, Genetic Alliance

Day 2-11:00 AM

Edmund Tai, PAMF
Marylyn D. Ritchie, Geisinger Health System
Defining Disease in a Vast Sea of Phenotypes
Justin Sonnenburg, Stanford University School of Medicine
Lucila Ohno-Machado, University of California San Diego

Day 2-11:15 AM

Kevin Knopf, Cancer Commons
Q&A
Lita M. Proctor, Human Microbiome Project
Sandra Soo-Jin Lee, Stanford University
Day 2-Sessions:

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Building Value for Liquid Biopsies in Oncology

Diagnostics Policy and the Impact on Innovation

Tumor Profiling to Clinical Action

Day 2-11:30 AM

Aris Baras, Regeneron Genetics Center
Opening Words by Session Chair
Frederic Pla, Genomic Health
Opening Words by Session Chair
Michael W. Nall, Biocept
Opening Words by Session Chair
Wolfgang Daum, Toma Biosciences
Opening Words by Session Chair

Day 2-11:45 AM

Kári Stefánsson, deCODE Genetics
Murali Krishna Prahalad, Epic Sciences
Actionable, Accurate and Accessible Liquid Biopsy
Louis Jacques, ADVI
Francisco M. De La Vega, Stanford University School of Medicine

Day 2-12:00 PM

George Yancopoulos, Regeneron Laboratories
Geoff Otto, Foundation Medicine
Development and Analytic Validation of a ctDNA Genomic Profiling Assay
Bonnie Anderson, Veracyte
Derrick Haslem, Intermountain Healthcare

Day 2- 12:15 PM

Richard Scheller, 23andMe
Paul Beresford, Biodesix
Discovering, Developing, Validating and Commercializing Liquid Biopsy Tests in Oncology
Q&AJoseph Tam, DiagCor

Day 2- 12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 2-Sessions:

The Secret to Wellness is Science

Beyond Genomics for Predicting Patient Response

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Achieving Accurate NGS Test Results


Day 2-1:30 PM

Lee Hood, Providence Health
Opening Words by Session Chair
Parker Cassidy, Mitra Biotech
Opening Words by Session Chair
Matt McLoughlin, Scientist.com
New Standard for Procuring Human Biospecimens
Russell Garlick, SeraCare
Opening Words by Session Chair

Day 2-1:45 PM

Jennifer Lovejoy, Arivale
Raanan Berger, Sheba Medical Center
Shiva Krupa, Biogen
Risks of Human Biospecimen Acquisition – Industry Perspective
Gregory Tsongalis, Dartmouth College
QC: Where the Rubber Meets the Road

Day 2-2:00 PM

Gil Omenn, University of Michigan
Udayan Guha, NIH
Brian Raudenbush, Boehringer Ingelheim Pharmaceuticals, Inc.
Challenges of Human Biospecimen Acquisition – Industry Perspective
Dara Aisner, University of Colorado School of Medicine
Confronting and Mitigating Pre-Analytic Variability

Day 2-2:15 PM

Q&AChristine A. Iacobuzio-Donahue, Memorial Sloan Kettering Cancer Center
Q&A
Q&A
Day 2-Sessions:

Immunotherapy: Immuno-checkpoint Inhibitors & Beyond

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

How to Make Rx-Dx Alliances Work

Scaling the 26-Hour Genome

Day 2-2:30 PM

Irv Weissman, Stanford School of Medicine
Opening Words by Session Chair
Walter Koch, Roche Molecular Systems, Inc.
Opening Words by Session Chair
Myla Lai-Goldman, GeneCentric Diagnostics
Words by Session Co-Chair
Pieter van Rooyen, Edico Genome
Opening Words by Session Chair

Day 2-2:45 PM

Jeffrey Bluestone, Parker Institute for Cancer Immunotherapy
Hacking Cancer with the Immune System
Helmy Eltoukhy , Guardant Health
Liquid Biopsy Applications and New Horizons
Eric Lai, Takeda
Words by Session Co-Chair
Dawn Barry, Illumina

Day 2-3:00 PM

Andrew Allen, Gritstone Oncology
Exploiting Mutations as Targets for the Immune System
Janine McMurdie, Agena Bioscience
Ultrasensitive Somatic Mutation Detection in cfDNA
Peter Collins, Premaitha Health
David Dimmock, Rady Children’s Hospital – San Diego

Day 2- 3:15 PM

Q&A
Q&A
Q&A
Q&A

Day 2- 3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

The Economics of Bringing Precision Medicine to the Clinic

Integrating Precision Medicine: Technical Challenges and Solutions

Progress in Improving the Evidence Base and Insurer Coverage

Day 2-4:00 PM

Brian Kelly, Quintiles
Paying for Precision Medicine: Perspectives from Other Countries
Eric Dishman, National Institutes of Health
Opening Words by Session Chair
Kathryn Phillips, UCSF
Reimbursement for Multigene Tests: The Good, The Bad, and The Ugly
Matthew McManus, Asuragen
Challenges to Creating Diagnostic Tests Across the Entire Genome

Day 2-4:15 PM

George Poste, Arizona State University
Opening Words by Session Chair
Lita M. Proctor, Human Microbiome Project
Joe Selby, PCORI
Patient-Centered Outcomes Research – in Support of Personalized Care
Track 4 Closing for Day 2

Day 2-4:30 PM

Roy Beveridge, Humana
David Glazer, Google
Patricia A. Deverka, American Institutes for Research
Pursuing Clinical Utility for Multi-Gene Tests and Genome-Scale Testing

Day 2-4:45 PM

Shari M. Ling, Centers for Medicare and Medicaid Services (CMS)
Gregory C. Simon, White House Cancer Moonshot Task Force
Q&A

Day 2- 5:00 PM

Lotte Steuten, Fred Hutchinson Cancer Research Center

How AI Will Humanize Clinical Diagnostics


Esteban Czwan, Sophia Genetics
Track 3 Closing for Day 2

Day 2- 5:15 PM

Track 1 Closing for Day 2

Track 2 Closing for Day 2

Time

Track 1

Track 2

Track 3

Track 4

Day 3-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 3-Sessions:

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Developing Successful Predictive Clinical Biomarkers

Day 3-8:00 AM

Jason Myers, ArcherDX
Opening Words by Session Chair
Ann Kapoun, Oncomed Pharma
Opening Words by Session Chair

Day 3-8:15 AM

Long Phi Le, Harvard Medical School
Mitch Raponi, Clovis Oncology

Day 3-8:30 AM

A. John Iafrate, Mass General
Terence Rhodes, Intermountain Healthcare
Current Immunotherapy Biomarkers and Future Directions
Neda Pakdaman, Stanford Medicine
Genetic Risk Assessment and Pharmacogenomics in Primary Care: A Pilot

Day 3-8:45 AM

Q&A
Carolyn Compton, National Biomarker Development Alliance
Developing Clinically Important (and Useful) Oncology Biomarkers: Challenges and Solutions
Jeffrey R. Luber, Good Start Genetics
Preconception Precision Testing: An Ounce of Prevention
Day 3-Sessions:

Precision Medicine Patent Law Update

Genetic Testing In Healthy Population

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Day 3-9:00 AM

Catherine Polizzi, Morrison & Foerster
Opening Words by Session Chair
Randy Scott, Invitae Corporation
Opening Words by Session Chair
Zaher Nahle, Solve ME/CFS Initiative
Opening Words by Session Chair

Day 3-9:15 AM

Michael Shuster, Fenwick & West
Robert C. Green, G2P
Genomic Sequencing in Healthy Individuals
Andreas Kogelnik, Open Medicine Institute (OMI)
Day 3-Sessions:

Biobanking Your Future

Genetic Testing In Healthy Population - Session Continued

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Continued

Day 3-9:30 AM

Nazneen Aziz, Kaiser Permanente
Role of Biobanks in Precision Medicine
Jordan Shlain, Private Medical
The Intersection of Primary Care & Genomics
Carol Head, Solve ME/CFS Initiative

Day 3-9:45 AM

Sumitra Muralidhar, VA
The Million Veteran Program: A Mega-Biobank for Precision Medicine
Justin Kao, Helix
The Future of Personal Genomics for All
Q&A

Day 3-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Complementary use of Digital PCR and NGS in Cancer Liquid Biopsy

Advancing the Clinic with Emerging NGS Technologies

Rare Disease Drug Development in Precision Medicine

How Immuno-oncology Saved My Life: A Patient’s Perspective

Day 3-10:30 AM

George Karlin-Neumann, Bio-Rad
Opening Words by Session Chair
Allison Ballmer, Roche
Opening Words by Session Chair
Mary Dixon Drake, Innovenn, Inc.
Opening Words by Session Chair
Andrew Schorr, Patient Power LLC
Opening Words by Session Chair

Day 3-10:45 AM

Lao Saal, SAGA Diagnostics AB
Tumor Heterogeneity and Circulating Tumor DNA Cancer Monitoring
Serge Saxonov, 10X Genomics
Marc Walton, Janssen
Natural History: Essential for Developing Rare Disease Therapies
Esther Schorr, Patient Power LLC

Day 3-11:00 AM

Isaac Garcia-Murillas, Institute of Cancer Research-UK
Prediction of Clinical Outcomes in Breast Cancer with ctDNA
Stefan Roever, Genia
Frank Czerwiec, Otsuka
Overcoming Data Challenges in Rare Disease Trials
Donald Stranathan, Patient Advocate

Day 3-11:15 AM

Lauren Ritterhouse, Harvard Medical School
Plasma cfDNA Mutation Detection in EGFR-Mutated Lung Cancer
Stephen Turner, Pacific Biosciences
Stephane Budel, DeciBio Consulting
Q&A
Lisa Goldman, Patient Advocate
Day 3-Sessions:

Expanding the Reach of Genomic Analysis

Clinical Trials in Immuno-therapy

Patient Power: The Changing Role of Individuals

Medical Devices and IoT: the Bridge to the Phenotype

Day 3-11:30 AM

Deanna Church, 10x Genomics
Opening Words by Session Chair
Patrice Hugo, Q2 Solutions
Opening Words by Session Chair
Cliff Reid, Genos Research
Opening Words by Session Chair
Sanjay Joshi, Dell EMC Emerging Technologies
Opening Words by Session Chair

Day 3-11:45 AM

Hanlee Ji, Stanford
Single Molecule and Cell Genomic and Immunologic Determinants of Cancer
Jonathan D. Cheng, Merck
Paul Billings, PlumCare LLC
Amer Haider, Doctella

Day 3-12:00 PM

Pui-Yan Kwok, UCSF
De novo Assembled Genomes for Full Genome Analysis
Samir N. Khleif, Augusta University
Linda Avey, Curious
Todd Gray, autonomous_ID

Day 3-12:15 PM

Q&A
James Novotny, Bristol-Myers Squibb
Jill Hagenkord, Color Genomics
Ashwin Pushpala, Sano
Manoj Dadlani, CosmosID

Day 3-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 3-Sessions:

CRISPR Technology – How It Has Changed Biological Research

Pathogen Specific Biologics for Infectious Diseases

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Podium Presentations

Day 3-1:30 PM

Jennifer Doudna, Berkeley
The Genome Engineering Revolution
Steven J. Projan, MedImmune
Opening Words by Session Chair
Ida Sim, UCSF
Opening Words by Session Chair
Steven Lynum, Panasonic Healthcare
Celebrating 50 Years in the Life Sciences

Day 3-1:45 PM

Shawn Shafer, MilliporeSigma
High Throughput Knockout Screening with CRISPR
René Russo, Arsanis
Targeted Prevention: The Future for Infectious Diseases
Sumbul Ahmad Desai, SHC
Ryan Witt, Immix BioPharma, Inc.
Pricing’s Looming Effect on I/O & PM

Day 3-2:00 PM

Jonathan S. Weissman, HHMI/UCSF
Controlling Gene Expression with CRISPRi and CRISPRa
Fred C. Tenover, Stanford University
Molecular Diagnostics: Patient Care and Clinical Trials
Ryan Howard, iBeat

Fireside Chat

Commercial Success to IPO: iRhythm CEO Interview
Casper de Clercq, Norwest Venture Partners

Day 3-2:15 PM

Q&A
David W. Martin, AvidBiotics Corp.
The Why and How of Pathogen-Specific Biologics
Q&A
Kevin King, iRythm Technologies
Day 3-Sessions:

NGS: Implementing a Clinical Workflow for All Constituents

Health Systems as Translational Research Partners

Track 3 Closing for Day 3Track 4 Closing for Day 3

Day 3-2:30 PM

Matthew Tindall, Omicia
Scaling Clinical NGS: From Panels to Exomes to WGS
Walter "Buzz" Stewart, Sutter Health
Opening Words by Session Chair

Day 3-2:45 PM

Kerry Kingham, Stanford
Genetic Counseling in the Clinic: Navigating and Translating Complex Results for the Patient
Joshua N. Liberman, Sutter Health
Precision Care for MS: Making It Work

Day 3-3:00 PM

Craig Parman, Bluebee
Bringing NGS Analytics from Research to the Clinic
Gregory J. Tranah, Sutter Health
Precision Medicine: Making It Work on Scale

Day 3-3:15 PM

Q&AQ&A

Day 3-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Companion Diagnostics: Where is the Incentive?

Company Competition Finals

TOP three finalists present to a VC panel and the audience
MC: Sheldon Schuster

Day 3-4:00 PM

Ed Winnick, GenomeWeb
Opening Words by Session Chair
Finalist 1

Day 3-4:15 PM

Mya Thomae, Illumina
Finalist 2

Day 3-4:30 PM

Sheila D. Walcoff, Goldbug Strategies
Finalist 3

Day 3-4:45 PM

Karen A. Heichman, ARUP
Winner is selected by panel of Judges
Day 3-Sessions:

The Global Alliance for Genomics and Health

Track 2 Closing for Day 3

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3

Time

Track 1

Track 2

Track 3

Track 4

Day 1

Day 1-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 1-8:00 AM


Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words
Track 1 Broadcast: Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words

Day 1-8:15 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients

Day 1-8:30 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Continued
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Continued

Company Competition Semi-Finals


Andrew Kurtz, NCI SBIR
Day 1-Sessions:

Immunotherapy: Emerging Applications and Therapies

Enabling Clinical-Grade NGS Testing

Company Competition Semi-Finals Continued

Day 1-8:45 AM

James Allison, MD Anderson Cancer Center
Opening Words by Session Chair
Sean Scott, Qiagen
Enabling Clinical-Grade NGS Testing “Dry Lab” Capabilities in Oncology
Abogen

Day 1-9:00 AM

Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immuno-oncology
Personalized Medicine - The Cinderella Story of Venture Investments?
Mara Aspinall, Genepeeks
Opening Words by Session Chair
Accelerated Medical Diagnostics

Day 1-9:15 AM

Debbie Law, Jounce Therapeutics
Developing JTX-2011 ICOS Agonist: A Translational Approach
Alexis Borisy, Third Rock Ventures
AccuraGen

Day 1-9:30 AM

James H. Godsey, Thermo Fisher Scientific
Addressing Immuno-oncology Research Challenges for Predictive Biomarkers
Andrew J. Schwab, 5AM Ventures
biomaRx

Day 1-9:45 AM

Q&A
Lindy Morris Fishburne, Breakout Labs
Cernostics

Day 1-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Issues and Challenges of Immunotherapy

The Value of Data Sharing

Company Competition Semi-Finals Continued

Emerging Infections: Tracking, Testing and Public Health Response

Day 1-10:30 AM

Lawrence Corey, Fred Hutchinson
Opening Words by Session Chair
John Leite, Illumina
John Shon, Illumina
Words by Session Co-Chair
Congenica Ltd.
Steve Miller, UCSF
Opening Words by Session Chair

Day 1-10:45 AM

Steve Harr, Juno Therapeutics
Lincoln Nadauld, Intermountain Healthcare
Sharon Terry, Genetic Alliance
CloudMedx
John Hackett, Abbott Laboratories
Challenges Associated With Development of Diagnostics to Emerging Agents

Day 1-11:00 AM

Ronald A. DePinho, MD Anderson Cancer Center
Juli Klemm, National Cancer Institute
Kathy Giusti, Multiple Myeloma Research Foundation
DName-iTDongxiang Xia, California Depart. of Public Health
Emerging Viral Infections: Lab Response

Day 1-11:15 AM

Crystal L. Mackall, Stanford University
Robert Nussbaum, Invitae
Gritstone Oncology
Q&A
Day 1-Sessions:

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Understanding Human Health and Diseases at the Individual Level

Company Competition Semi-Finals Continued

An Update on the Cancer Moonshot Blood Profiling Atlas

Day 1-11:30 AM

Brad Gray, NanoString Technologies
Opening Words by Session Chair
Euan Ashley, Stanford
Opening Words by Session Chair
Inanovate
Bruce Press, Seven Bridges
Opening Words by Session Chair

Day 1-11:45 AM

Kenneth Emancipator, Merck
Richard Chen, Personalis
Precision Medicine for Immuno-Oncology: Personalized Cancer Vaccines and Diagnostics
Inmedix
Howard I. Scher, Memorial Sloan Kettering Cancer Center

Day 1-12:00 PM

Daniel Chen, Genentech
Jessica Mega, Verily
JBS Science
Geoff Otto, Foundation Medicine

Day 1-12:15 PM

Steven Averbuch, Bristol-Myers Squibb
Sowmi Utiramerur, Stanford Health Care
KIYATEC
Q&A

Day 1-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 1-Sessions:

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Company Competition Semi-Finals Continued

Reaching New Heights in Sequencing

Day 1-1:30 PM

Chris Cournoyer, N-of-One
Opening Words by Session Chair
John Ryals, Metabolon
Metabolomics and Its Role in Precision Medicine
Sequence BioMirna Jarosz, IDT
Methods for Accurate Variant Detection in cfDNA

Day 1-1:45 PM

Donald L. (Skip) Trump, Inova Schar Cancer Institute.
Emily Leproust, Twist Bioscience
Rewriting DNA Synthesis
Standigm
Alexander Bisignano, Phosphorous
A Distributed Clinical Data Network

Day 1-2:00 PM

Thomas D. Brown, Swedish Cancer Institute
Gautam Kollu, Illumina
Diagnosing genetic diseases using Whole Genome Sequencing
Two Pore Guys
Frederick Lee Baehner, Genomic Health
Where Value Based Care and Precision Medicine Converge

Day 1-2:15 PM

Q&A
Summerpal Kahlon, Oracle
Intelligent Care: Translating Data into Insight
Vitatex
Kaja Milanowska, Ardigen SA
Artificial Intelligence for Personalized Medicine
Day 1-Sessions:

Importance of Standardized Assays for Precision Medicine

Clinical Applications of ctDNA in Cancer Management

Emerging Technologies

Learnings from Precision Medicine Centers

Day 1-2:30 PM

Jeffrey Edward Miller, Invivoscribe
Opening Words by Session Chair
Clive Morris, Inivata
The Future of ctDNA
Fabien Beckers, Arterys
Adding Medical Imaging Features to Precision Medicine
Berta Strulovici, The Israel National Center for PM
Integrated Technological Platforms in Israel

Day 1-2:45 PM

Bradley Patay, Genection
Importance of Design Controlled Assays in Hematopathology
Nitzan Rosenfeld, Inivata
Targeted Deep Sequencing of Circulating Tumor DNA
Stephen J. Matlin, Life Length
Telomeres: Unlocking The Aging Code
Mathias Uhlen, SciLifeLab
The SCAPIS SciLifeLab Wellness Profiling Program

Day 1-3:00 PM

Mark Levis, Johns Hopkins University
Acute Myeloid Leukemia: Bringing Order Out of Chaos
Ramaswamy Govindan, Washington University School of Medicine
ctDNA in the Treatment of Lung Cancer- Opportunities and Challenges
Stephen Quake, Stanford University
Precision Measurements in Biology
Vandhana Krishnan, Stanford University
Assessment of Variant Calling Pipelines for Clinical Diagnosis

Day 1-3:15 PM

Q&A
Q&A
Nick Lench, Congenica
Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes
Cuiping Pan, VA Palo Alto
Million Veteran Program Builds a Mega-biobank for Human Disease Research

Day 1-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Leveraging Chip Technologies for Healthcare

Moving Precision Medicine to Precision Health

Podium Presentations

Adoption of Precision Medicine: Hereditary Cancer

Day 1-4:00 PM

Roeland Huys, imecHarold L. Paz, Aetna
Opening Words by Session Chair
Boris Hayete, GNS Healthcare
Parkinson’s Disease: in Search of Predictors of Progression
Taylor Sittler, Color Genomics
Opening Words by Session Chair

Day 1-4:15 PM

Clinical Next-Generation Sequencing for Infectious Disease Diagnosis


Charles Chiu, UCSF
Opening Words by Session Chair
Lincoln Nadauld, Intermountain Healthcare
Paul Docherty, Hologic
Diagnostic: Pharma Relationships in CDx Development
Kevin Hughes, Harvard Medical School

Day 1-4:30 PM

Robert Schlaberg, IDbyDNA Inc.
Dx Application of NGS Tests for Infectious Diseases
Amy Burd, LLS
George Vasmatzis, Mayo Clinic
Detecting Rearrangements Using NGS and Applications to Biomarker Discovery
Theodora Ross, UT Southwestern Medical Center

Day 1-4:45 PM

Heike Sichtig, US Food and Drug Administration
FDA’s Role and Tools for ID-NGS Diagnostics
Harlan Krumholz, Yale School of Medicine
Fred Streitz, Lawrence Livermore National Laboratory
Accelerating Cancer Research with Extreme Scale Computing
Heather Hampel, The Ohio State University Wexner Medical Center

Day 1- 5:00 PM

Mickey Kertesz, Karius, Inc.
Infectious Disease Diagnostics for the Genomic Era

An Update on the Cancer Moonshot and Brain Government Initiatives


Joshua Gordon, National Institute of Mental Health
Update from the NIMH: Precision Medicine and the BRAIN Initiative

Day 1- 5:15 PM

Track 1 Closing for Day 1

Track 2 Closing for Day 1

Track 3 Closing for Day 1Track 4 Closing for Day 1
Day 2

Day 2-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 2-Sessions:

How Scientific Wellness Will Transform Healthcare

An Update on the Cancer Moonshot and Brain Government Initiatives (Cont.)

Day 2-7:30 AM

Lee Hood, Providence Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force
Walking On The Moon: Reflections

Podium Presentations

Peter Donnelly, Oxford University
Learning the Human Wiring Diagram from Genomics

Day 2-7:45 AM

Rodney F. Hochman, Providence St. Joseph Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force- Continued
Walking On The Moon: Reflections
Eric Kowack, Ignyta
An Innovative Approach For Dx-Driven Oncology Trials

Unlocking Real-World Clinical Data


Sean Scott, Qiagen
Integrating NGS-based Test Results with Clinical Outcomes Data to Improve Physician Decision Support
Day 2-Sessions:

How Molecular Subtyping Can Aid Clinical Drug Development

Population Precision Medicine
Presented by India Hook-Barnard

Podium Presentations Continued

Unlocking Real-World Clinical Data continued

Day 2-8:00 AM

Janusz Dutkowski, Data4Cure
Opening Words by Session Chair
Kirsten Bibbins-Domingo, UCSF
Opening Words by Session Chair
Amy Burd, LLS
Introducing a New Concept in AML
Amy Abernethy, Flatiron Health
Opening Words by Session Chair

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:30 AM

How to Commercialize Technologies That Advance PM


Alex De Winter, GE Ventures
Fireside Chat
Robert A. Hiatt, UCSF

Driving Value for Genomics Startups


Amanda Cashin, Illumina Accelerator
George Komatsoulis, CancerLinQ
Big Data in Cancer Care

Day 2-8:45 AM

Mark Fischer-Colbrie, Labcyte
Fireside Chat
Q&A
Trevor Levin, UrologyDx
Nick Conley, Epibiome
Phong Le, HPE
Preparing for the Next Step in Genomic Analysis
Day 2-Sessions:

New Healthcare Paradigm from the $100 Genome

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Enabling Advances in Human Microbiome Research

CIAPM: Accelerating Precision Medicine Advances in California

Day 2-9:00 AM

Yiwu He, BGI
Implications of $100 Whole Genome Sequencing
Assaf Halevy, 2bPrecise
Opening Words by Session Chair
Nick Conley, Epibiome
Opening Words by Session Chair
Elizabeth Baca, Governor's Office of Planning and Research
Opening Words by Session Chair

Day 2-9:15 AM

Q&A
Holli Hutcheson Dilks, Sarah Cannon Research InstituteDavid Mills, UC Davis
Restoring Ecosystem Function in the Infant Microbiome
Uta Grieshammer, CIAPM

Day 2-9:30 AM

Rade Drmanac, Complete Genomics, Inc. (a BGI company)
Efficient WGS as Foundation for Precision Medicine
John Mattison, Kaiser PermanenteSusan Lynch, Siolta Therapeutics
The Gut Microbiome and Childhood Allergic Asthma
Nicholas Anderson, UC Davis
Rowan Chapman, Johnson & Johnson Innovation - California

Day 2- 9:45 AM

Q&A
Amy Urban, UPMC
Joel Diamond, 2bPrecise
Lihi Segal , DayTwo
Personalized Nutrition Using Gut Microbiome and Clinical Data
Brennan Spiegel, Cedars-Sinai
Olena Morozova, UCSC

Day 2-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

How To Engage Community Oncologists in Precision Medicine

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Emerging Themes in the Human Microbiome

Data Sharing: Patient Rights and Privacy

Day 2-10:30 AM

Lincoln Nadauld, Intermountain Healthcare
Laurence Marton, PMWC 2014 Session Chair
Words by Session Co-Chair
Atul Butte, UCSF
Driving Disease Understanding and Treatment via a Centralized Data Warehouse
Michael Fischbach, California Institute for Quantitative Biosciences (QB3)
Opening Words by Session Chair
William Knox Carey, Genecloud
Opening Words by Session Chair

Day 2-10:45 AM

Tim Collins, Scripps Health
Diane Wuest, GNS Healthcare
Unlocking Precise Knowledge within Complex Data via Causal Machine Learning
Erica Sonnenburg, Stanford University School of Medicine
Sharon Terry, Genetic Alliance

Day 2-11:00 AM

Edmund Tai, PAMF
Marylyn D. Ritchie, Geisinger Health System
Defining Disease in a Vast Sea of Phenotypes
Justin Sonnenburg, Stanford University School of Medicine
Lucila Ohno-Machado, University of California San Diego

Day 2-11:15 AM

Kevin Knopf, Cancer Commons
Q&A
Lita M. Proctor, Human Microbiome Project
Sandra Soo-Jin Lee, Stanford University
Day 2-Sessions:

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Building Value for Liquid Biopsies in Oncology

Diagnostics Policy and the Impact on Innovation

Tumor Profiling to Clinical Action

Day 2-11:30 AM

Aris Baras, Regeneron Genetics Center
Opening Words by Session Chair
Frederic Pla, Genomic Health
Opening Words by Session Chair
Michael W. Nall, Biocept
Opening Words by Session Chair
Wolfgang Daum, Toma Biosciences
Opening Words by Session Chair

Day 2-11:45 AM

Kári Stefánsson, deCODE Genetics
Murali Krishna Prahalad, Epic Sciences
Actionable, Accurate and Accessible Liquid Biopsy
Louis Jacques, ADVI
Francisco M. De La Vega, Stanford University School of Medicine

Day 2-12:00 PM

George Yancopoulos, Regeneron Laboratories
Geoff Otto, Foundation Medicine
Development and Analytic Validation of a ctDNA Genomic Profiling Assay
Bonnie Anderson, Veracyte
Derrick Haslem, Intermountain Healthcare

Day 2- 12:15 PM

Richard Scheller, 23andMe
Paul Beresford, Biodesix
Discovering, Developing, Validating and Commercializing Liquid Biopsy Tests in Oncology
Q&AJoseph Tam, DiagCor

Day 2- 12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 2-Sessions:

The Secret to Wellness is Science

Beyond Genomics for Predicting Patient Response

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Achieving Accurate NGS Test Results


Day 2-1:30 PM

Lee Hood, Providence Health
Opening Words by Session Chair
Parker Cassidy, Mitra Biotech
Opening Words by Session Chair
Matt McLoughlin, Scientist.com
New Standard for Procuring Human Biospecimens
Russell Garlick, SeraCare
Opening Words by Session Chair

Day 2-1:45 PM

Jennifer Lovejoy, Arivale
Raanan Berger, Sheba Medical Center
Shiva Krupa, Biogen
Risks of Human Biospecimen Acquisition – Industry Perspective
Gregory Tsongalis, Dartmouth College
QC: Where the Rubber Meets the Road

Day 2-2:00 PM

Gil Omenn, University of Michigan
Udayan Guha, NIH
Brian Raudenbush, Boehringer Ingelheim Pharmaceuticals, Inc.
Challenges of Human Biospecimen Acquisition – Industry Perspective
Dara Aisner, University of Colorado School of Medicine
Confronting and Mitigating Pre-Analytic Variability

Day 2-2:15 PM

Q&AChristine A. Iacobuzio-Donahue, Memorial Sloan Kettering Cancer Center
Q&A
Q&A
Day 2-Sessions:

Immunotherapy: Immuno-checkpoint Inhibitors & Beyond

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

How to Make Rx-Dx Alliances Work

Scaling the 26-Hour Genome

Day 2-2:30 PM

Irv Weissman, Stanford School of Medicine
Opening Words by Session Chair
Walter Koch, Roche Molecular Systems, Inc.
Opening Words by Session Chair
Myla Lai-Goldman, GeneCentric Diagnostics
Words by Session Co-Chair
Pieter van Rooyen, Edico Genome
Opening Words by Session Chair

Day 2-2:45 PM

Jeffrey Bluestone, Parker Institute for Cancer Immunotherapy
Hacking Cancer with the Immune System
Helmy Eltoukhy , Guardant Health
Liquid Biopsy Applications and New Horizons
Eric Lai, Takeda
Words by Session Co-Chair
Dawn Barry, Illumina

Day 2-3:00 PM

Andrew Allen, Gritstone Oncology
Exploiting Mutations as Targets for the Immune System
Janine McMurdie, Agena Bioscience
Ultrasensitive Somatic Mutation Detection in cfDNA
Peter Collins, Premaitha Health
David Dimmock, Rady Children’s Hospital – San Diego

Day 2- 3:15 PM

Q&A
Q&A
Q&A
Q&A

Day 2- 3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

The Economics of Bringing Precision Medicine to the Clinic

Integrating Precision Medicine: Technical Challenges and Solutions

Progress in Improving the Evidence Base and Insurer Coverage

Day 2-4:00 PM

Brian Kelly, Quintiles
Paying for Precision Medicine: Perspectives from Other Countries
Eric Dishman, National Institutes of Health
Opening Words by Session Chair
Kathryn Phillips, UCSF
Reimbursement for Multigene Tests: The Good, The Bad, and The Ugly
Matthew McManus, Asuragen
Challenges to Creating Diagnostic Tests Across the Entire Genome

Day 2-4:15 PM

George Poste, Arizona State University
Opening Words by Session Chair
Lita M. Proctor, Human Microbiome Project
Joe Selby, PCORI
Patient-Centered Outcomes Research – in Support of Personalized Care
Track 4 Closing for Day 2

Day 2-4:30 PM

Roy Beveridge, Humana
David Glazer, Google
Patricia A. Deverka, American Institutes for Research
Pursuing Clinical Utility for Multi-Gene Tests and Genome-Scale Testing

Day 2-4:45 PM

Shari M. Ling, Centers for Medicare and Medicaid Services (CMS)
Gregory C. Simon, White House Cancer Moonshot Task Force
Q&A

Day 2- 5:00 PM

Lotte Steuten, Fred Hutchinson Cancer Research Center

How AI Will Humanize Clinical Diagnostics


Esteban Czwan, Sophia Genetics
Track 3 Closing for Day 2

Day 2- 5:15 PM

Track 1 Closing for Day 2

Track 2 Closing for Day 2

Day 3

Day 3-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 3-Sessions:

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Developing Successful Predictive Clinical Biomarkers

Day 3-8:00 AM

Jason Myers, ArcherDX
Opening Words by Session Chair
Ann Kapoun, Oncomed Pharma
Opening Words by Session Chair

Day 3-8:15 AM

Long Phi Le, Harvard Medical School
Mitch Raponi, Clovis Oncology

Day 3-8:30 AM

A. John Iafrate, Mass General
Terence Rhodes, Intermountain Healthcare
Current Immunotherapy Biomarkers and Future Directions
Neda Pakdaman, Stanford Medicine
Genetic Risk Assessment and Pharmacogenomics in Primary Care: A Pilot

Day 3-8:45 AM

Q&A
Carolyn Compton, National Biomarker Development Alliance
Developing Clinically Important (and Useful) Oncology Biomarkers: Challenges and Solutions
Jeffrey R. Luber, Good Start Genetics
Preconception Precision Testing: An Ounce of Prevention
Day 3-Sessions:

Precision Medicine Patent Law Update

Genetic Testing In Healthy Population

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Day 3-9:00 AM

Catherine Polizzi, Morrison & Foerster
Opening Words by Session Chair
Randy Scott, Invitae Corporation
Opening Words by Session Chair
Zaher Nahle, Solve ME/CFS Initiative
Opening Words by Session Chair

Day 3-9:15 AM

Michael Shuster, Fenwick & West
Robert C. Green, G2P
Genomic Sequencing in Healthy Individuals
Andreas Kogelnik, Open Medicine Institute (OMI)
Day 3-Sessions:

Biobanking Your Future

Genetic Testing In Healthy Population - Session Continued

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Continued

Day 3-9:30 AM

Nazneen Aziz, Kaiser Permanente
Role of Biobanks in Precision Medicine
Jordan Shlain, Private Medical
The Intersection of Primary Care & Genomics
Carol Head, Solve ME/CFS Initiative

Day 3-9:45 AM

Sumitra Muralidhar, VA
The Million Veteran Program: A Mega-Biobank for Precision Medicine
Justin Kao, Helix
The Future of Personal Genomics for All
Q&A

Day 3-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Complementary use of Digital PCR and NGS in Cancer Liquid Biopsy

Advancing the Clinic with Emerging NGS Technologies

Rare Disease Drug Development in Precision Medicine

How Immuno-oncology Saved My Life: A Patient’s Perspective

Day 3-10:30 AM

George Karlin-Neumann, Bio-Rad
Opening Words by Session Chair
Allison Ballmer, Roche
Opening Words by Session Chair
Mary Dixon Drake, Innovenn, Inc.
Opening Words by Session Chair
Andrew Schorr, Patient Power LLC
Opening Words by Session Chair

Day 3-10:45 AM

Lao Saal, SAGA Diagnostics AB
Tumor Heterogeneity and Circulating Tumor DNA Cancer Monitoring
Serge Saxonov, 10X Genomics
Marc Walton, Janssen
Natural History: Essential for Developing Rare Disease Therapies
Esther Schorr, Patient Power LLC

Day 3-11:00 AM

Isaac Garcia-Murillas, Institute of Cancer Research-UK
Prediction of Clinical Outcomes in Breast Cancer with ctDNA
Stefan Roever, Genia
Frank Czerwiec, Otsuka
Overcoming Data Challenges in Rare Disease Trials
Donald Stranathan, Patient Advocate

Day 3-11:15 AM

Lauren Ritterhouse, Harvard Medical School
Plasma cfDNA Mutation Detection in EGFR-Mutated Lung Cancer
Stephen Turner, Pacific Biosciences
Stephane Budel, DeciBio Consulting
Q&A
Lisa Goldman, Patient Advocate
Day 3-Sessions:

Expanding the Reach of Genomic Analysis

Clinical Trials in Immuno-therapy

Patient Power: The Changing Role of Individuals

Medical Devices and IoT: the Bridge to the Phenotype

Day 3-11:30 AM

Deanna Church, 10x Genomics
Opening Words by Session Chair
Patrice Hugo, Q2 Solutions
Opening Words by Session Chair
Cliff Reid, Genos Research
Opening Words by Session Chair
Sanjay Joshi, Dell EMC Emerging Technologies
Opening Words by Session Chair

Day 3-11:45 AM

Hanlee Ji, Stanford
Single Molecule and Cell Genomic and Immunologic Determinants of Cancer
Jonathan D. Cheng, Merck
Paul Billings, PlumCare LLC
Amer Haider, Doctella

Day 3-12:00 PM

Pui-Yan Kwok, UCSF
De novo Assembled Genomes for Full Genome Analysis
Samir N. Khleif, Augusta University
Linda Avey, Curious
Todd Gray, autonomous_ID

Day 3-12:15 PM

Q&A
James Novotny, Bristol-Myers Squibb
Jill Hagenkord, Color Genomics
Ashwin Pushpala, Sano
Manoj Dadlani, CosmosID

Day 3-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 3-Sessions:

CRISPR Technology – How It Has Changed Biological Research

Pathogen Specific Biologics for Infectious Diseases

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Podium Presentations

Day 3-1:30 PM

Jennifer Doudna, Berkeley
The Genome Engineering Revolution
Steven J. Projan, MedImmune
Opening Words by Session Chair
Ida Sim, UCSF
Opening Words by Session Chair
Steven Lynum, Panasonic Healthcare
Celebrating 50 Years in the Life Sciences

Day 3-1:45 PM

Shawn Shafer, MilliporeSigma
High Throughput Knockout Screening with CRISPR
René Russo, Arsanis
Targeted Prevention: The Future for Infectious Diseases
Sumbul Ahmad Desai, SHC
Ryan Witt, Immix BioPharma, Inc.
Pricing’s Looming Effect on I/O & PM

Day 3-2:00 PM

Jonathan S. Weissman, HHMI/UCSF
Controlling Gene Expression with CRISPRi and CRISPRa
Fred C. Tenover, Stanford University
Molecular Diagnostics: Patient Care and Clinical Trials
Ryan Howard, iBeat

Fireside Chat

Commercial Success to IPO: iRhythm CEO Interview
Casper de Clercq, Norwest Venture Partners

Day 3-2:15 PM

Q&A
David W. Martin, AvidBiotics Corp.
The Why and How of Pathogen-Specific Biologics
Q&A
Kevin King, iRythm Technologies
Day 3-Sessions:

NGS: Implementing a Clinical Workflow for All Constituents

Health Systems as Translational Research Partners

Track 3 Closing for Day 3Track 4 Closing for Day 3

Day 3-2:30 PM

Matthew Tindall, Omicia
Scaling Clinical NGS: From Panels to Exomes to WGS
Walter "Buzz" Stewart, Sutter Health
Opening Words by Session Chair

Day 3-2:45 PM

Kerry Kingham, Stanford
Genetic Counseling in the Clinic: Navigating and Translating Complex Results for the Patient
Joshua N. Liberman, Sutter Health
Precision Care for MS: Making It Work

Day 3-3:00 PM

Craig Parman, Bluebee
Bringing NGS Analytics from Research to the Clinic
Gregory J. Tranah, Sutter Health
Precision Medicine: Making It Work on Scale

Day 3-3:15 PM

Q&AQ&A

Day 3-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Companion Diagnostics: Where is the Incentive?

Company Competition Finals

TOP three finalists present to a VC panel and the audience
MC: Sheldon Schuster

Day 3-4:00 PM

Ed Winnick, GenomeWeb
Opening Words by Session Chair
Finalist 1

Day 3-4:15 PM

Mya Thomae, Illumina
Finalist 2

Day 3-4:30 PM

Sheila D. Walcoff, Goldbug Strategies
Finalist 3

Day 3-4:45 PM

Karen A. Heichman, ARUP
Winner is selected by panel of Judges
Day 3-Sessions:

The Global Alliance for Genomics and Health

Track 2 Closing for Day 3

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3

Time

Track 1

Track 2

Track 3

Track 4

Day 1-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 1-8:00 AM


Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words
Track 1 Broadcast: Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words

Day 1-8:15 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients

Day 1-8:30 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Continued
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Continued

Company Competition Semi-Finals


Andrew Kurtz, NCI SBIR
Day 1-Sessions:

Immunotherapy: Emerging Applications and Therapies

Enabling Clinical-Grade NGS Testing

Company Competition Semi-Finals Continued

Day 1-8:45 AM

James Allison, MD Anderson Cancer Center
Opening Words by Session Chair
Sean Scott, Qiagen
Enabling Clinical-Grade NGS Testing “Dry Lab” Capabilities in Oncology
Abogen

Day 1-9:00 AM

Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immuno-oncology
Personalized Medicine - The Cinderella Story of Venture Investments?
Mara Aspinall, Genepeeks
Opening Words by Session Chair
Accelerated Medical Diagnostics

Day 1-9:15 AM

Debbie Law, Jounce Therapeutics
Developing JTX-2011 ICOS Agonist: A Translational Approach
Alexis Borisy, Third Rock Ventures
AccuraGen

Day 1-9:30 AM

James H. Godsey, Thermo Fisher Scientific
Addressing Immuno-oncology Research Challenges for Predictive Biomarkers
Andrew J. Schwab, 5AM Ventures
biomaRx

Day 1-9:45 AM

Q&A
Lindy Morris Fishburne, Breakout Labs
Cernostics

Day 1-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Issues and Challenges of Immunotherapy

The Value of Data Sharing

Company Competition Semi-Finals Continued

Emerging Infections: Tracking, Testing and Public Health Response

Day 1-10:30 AM

Lawrence Corey, Fred Hutchinson
Opening Words by Session Chair
John Leite, Illumina
John Shon, Illumina
Words by Session Co-Chair
Congenica Ltd.
Steve Miller, UCSF
Opening Words by Session Chair

Day 1-10:45 AM

Steve Harr, Juno Therapeutics
Lincoln Nadauld, Intermountain Healthcare
Sharon Terry, Genetic Alliance
CloudMedx
John Hackett, Abbott Laboratories
Challenges Associated With Development of Diagnostics to Emerging Agents

Day 1-11:00 AM

Ronald A. DePinho, MD Anderson Cancer Center
Juli Klemm, National Cancer Institute
Kathy Giusti, Multiple Myeloma Research Foundation
DName-iTDongxiang Xia, California Depart. of Public Health
Emerging Viral Infections: Lab Response

Day 1-11:15 AM

Crystal L. Mackall, Stanford University
Robert Nussbaum, Invitae
Gritstone Oncology
Q&A
Day 1-Sessions:

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Understanding Human Health and Diseases at the Individual Level

Company Competition Semi-Finals Continued

An Update on the Cancer Moonshot Blood Profiling Atlas

Day 1-11:30 AM

Brad Gray, NanoString Technologies
Opening Words by Session Chair
Euan Ashley, Stanford
Opening Words by Session Chair
Inanovate
Bruce Press, Seven Bridges
Opening Words by Session Chair

Day 1-11:45 AM

Kenneth Emancipator, Merck
Richard Chen, Personalis
Precision Medicine for Immuno-Oncology: Personalized Cancer Vaccines and Diagnostics
Inmedix
Howard I. Scher, Memorial Sloan Kettering Cancer Center

Day 1-12:00 PM

Daniel Chen, Genentech
Jessica Mega, Verily
JBS Science
Geoff Otto, Foundation Medicine

Day 1-12:15 PM

Steven Averbuch, Bristol-Myers Squibb
Sowmi Utiramerur, Stanford Health Care
KIYATEC
Q&A

Day 1-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 1-Sessions:

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Company Competition Semi-Finals Continued

Reaching New Heights in Sequencing

Day 1-1:30 PM

Chris Cournoyer, N-of-One
Opening Words by Session Chair
John Ryals, Metabolon
Metabolomics and Its Role in Precision Medicine
Sequence BioMirna Jarosz, IDT
Methods for Accurate Variant Detection in cfDNA

Day 1-1:45 PM

Donald L. (Skip) Trump, Inova Schar Cancer Institute.
Emily Leproust, Twist Bioscience
Rewriting DNA Synthesis
Standigm
Alexander Bisignano, Phosphorous
A Distributed Clinical Data Network

Day 1-2:00 PM

Thomas D. Brown, Swedish Cancer Institute
Gautam Kollu, Illumina
Diagnosing genetic diseases using Whole Genome Sequencing
Two Pore Guys
Frederick Lee Baehner, Genomic Health
Where Value Based Care and Precision Medicine Converge

Day 1-2:15 PM

Q&A
Summerpal Kahlon, Oracle
Intelligent Care: Translating Data into Insight
Vitatex
Kaja Milanowska, Ardigen SA
Artificial Intelligence for Personalized Medicine
Day 1-Sessions:

Importance of Standardized Assays for Precision Medicine

Clinical Applications of ctDNA in Cancer Management

Emerging Technologies

Learnings from Precision Medicine Centers

Day 1-2:30 PM

Jeffrey Edward Miller, Invivoscribe
Opening Words by Session Chair
Clive Morris, Inivata
The Future of ctDNA
Fabien Beckers, Arterys
Adding Medical Imaging Features to Precision Medicine
Berta Strulovici, The Israel National Center for PM
Integrated Technological Platforms in Israel

Day 1-2:45 PM

Bradley Patay, Genection
Importance of Design Controlled Assays in Hematopathology
Nitzan Rosenfeld, Inivata
Targeted Deep Sequencing of Circulating Tumor DNA
Stephen J. Matlin, Life Length
Telomeres: Unlocking The Aging Code
Mathias Uhlen, SciLifeLab
The SCAPIS SciLifeLab Wellness Profiling Program

Day 1-3:00 PM

Mark Levis, Johns Hopkins University
Acute Myeloid Leukemia: Bringing Order Out of Chaos
Ramaswamy Govindan, Washington University School of Medicine
ctDNA in the Treatment of Lung Cancer- Opportunities and Challenges
Stephen Quake, Stanford University
Precision Measurements in Biology
Vandhana Krishnan, Stanford University
Assessment of Variant Calling Pipelines for Clinical Diagnosis

Day 1-3:15 PM

Q&A
Q&A
Nick Lench, Congenica
Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes
Cuiping Pan, VA Palo Alto
Million Veteran Program Builds a Mega-biobank for Human Disease Research

Day 1-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Leveraging Chip Technologies for Healthcare

Moving Precision Medicine to Precision Health

Podium Presentations

Adoption of Precision Medicine: Hereditary Cancer

Day 1-4:00 PM

Roeland Huys, imecHarold L. Paz, Aetna
Opening Words by Session Chair
Boris Hayete, GNS Healthcare
Parkinson’s Disease: in Search of Predictors of Progression
Taylor Sittler, Color Genomics
Opening Words by Session Chair

Day 1-4:15 PM

Clinical Next-Generation Sequencing for Infectious Disease Diagnosis


Charles Chiu, UCSF
Opening Words by Session Chair
Lincoln Nadauld, Intermountain Healthcare
Paul Docherty, Hologic
Diagnostic: Pharma Relationships in CDx Development
Kevin Hughes, Harvard Medical School

Day 1-4:30 PM

Robert Schlaberg, IDbyDNA Inc.
Dx Application of NGS Tests for Infectious Diseases
Amy Burd, LLS
George Vasmatzis, Mayo Clinic
Detecting Rearrangements Using NGS and Applications to Biomarker Discovery
Theodora Ross, UT Southwestern Medical Center

Day 1-4:45 PM

Heike Sichtig, US Food and Drug Administration
FDA’s Role and Tools for ID-NGS Diagnostics
Harlan Krumholz, Yale School of Medicine
Fred Streitz, Lawrence Livermore National Laboratory
Accelerating Cancer Research with Extreme Scale Computing
Heather Hampel, The Ohio State University Wexner Medical Center

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3

Day 1- 5:15 PM

Track 1 Closing for Day 1

Track 2 Closing for Day 1

Track 3 Closing for Day 1Track 4 Closing for Day 1
Day 2

Time

Track 1

Track 2

Track 3

Track 4

Day 2-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 2-Sessions:

How Scientific Wellness Will Transform Healthcare

An Update on the Cancer Moonshot and Brain Government Initiatives (Cont.)

Day 2-7:30 AM

Lee Hood, Providence Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force
Walking On The Moon: Reflections

Podium Presentations

Peter Donnelly, Oxford University
Learning the Human Wiring Diagram from Genomics

Day 2-7:45 AM

Rodney F. Hochman, Providence St. Joseph Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force- Continued
Walking On The Moon: Reflections
Eric Kowack, Ignyta
An Innovative Approach For Dx-Driven Oncology Trials

Unlocking Real-World Clinical Data


Sean Scott, Qiagen
Integrating NGS-based Test Results with Clinical Outcomes Data to Improve Physician Decision Support
Day 2-Sessions:

How Molecular Subtyping Can Aid Clinical Drug Development

Population Precision Medicine
Presented by India Hook-Barnard

Podium Presentations Continued

Unlocking Real-World Clinical Data continued

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:30 AM

How to Commercialize Technologies That Advance PM


Alex De Winter, GE Ventures
Fireside Chat
Robert A. Hiatt, UCSF

Driving Value for Genomics Startups


Amanda Cashin, Illumina Accelerator
George Komatsoulis, CancerLinQ
Big Data in Cancer Care

Day 2-8:45 AM

Mark Fischer-Colbrie, Labcyte
Fireside Chat
Q&A
Trevor Levin, UrologyDx
Nick Conley, Epibiome
Phong Le, HPE
Preparing for the Next Step in Genomic Analysis
Day 2-Sessions:

New Healthcare Paradigm from the $100 Genome

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Enabling Advances in Human Microbiome Research

CIAPM: Accelerating Precision Medicine Advances in California

Day 2-9:00 AM

Yiwu He, BGI
Implications of $100 Whole Genome Sequencing
Assaf Halevy, 2bPrecise
Opening Words by Session Chair
Nick Conley, Epibiome
Opening Words by Session Chair
Elizabeth Baca, Governor's Office of Planning and Research
Opening Words by Session Chair

Day 2-9:15 AM

Q&A
Holli Hutcheson Dilks, Sarah Cannon Research InstituteDavid Mills, UC Davis
Restoring Ecosystem Function in the Infant Microbiome
Uta Grieshammer, CIAPM

Day 2-9:30 AM

Rade Drmanac, Complete Genomics, Inc. (a BGI company)
Efficient WGS as Foundation for Precision Medicine
John Mattison, Kaiser PermanenteSusan Lynch, Siolta Therapeutics
The Gut Microbiome and Childhood Allergic Asthma
Nicholas Anderson, UC Davis
Rowan Chapman, Johnson & Johnson Innovation - California

Day 2- 9:45 AM

Q&A
Amy Urban, UPMC
Joel Diamond, 2bPrecise
Lihi Segal , DayTwo
Personalized Nutrition Using Gut Microbiome and Clinical Data
Brennan Spiegel, Cedars-Sinai
Olena Morozova, UCSC

Day 2-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

How To Engage Community Oncologists in Precision Medicine

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Emerging Themes in the Human Microbiome

Data Sharing: Patient Rights and Privacy

Day 2-10:30 AM

Lincoln Nadauld, Intermountain Healthcare
Laurence Marton, PMWC 2014 Session Chair
Words by Session Co-Chair
Atul Butte, UCSF
Driving Disease Understanding and Treatment via a Centralized Data Warehouse
Michael Fischbach, California Institute for Quantitative Biosciences (QB3)
Opening Words by Session Chair
William Knox Carey, Genecloud
Opening Words by Session Chair

Day 2-10:45 AM

Tim Collins, Scripps Health
Diane Wuest, GNS Healthcare
Unlocking Precise Knowledge within Complex Data via Causal Machine Learning
Erica Sonnenburg, Stanford University School of Medicine
Sharon Terry, Genetic Alliance

Day 2-11:00 AM

Edmund Tai, PAMF
Marylyn D. Ritchie, Geisinger Health System
Defining Disease in a Vast Sea of Phenotypes
Justin Sonnenburg, Stanford University School of Medicine
Lucila Ohno-Machado, University of California San Diego

Day 2-11:15 AM

Kevin Knopf, Cancer Commons
Q&A
Lita M. Proctor, Human Microbiome Project
Sandra Soo-Jin Lee, Stanford University
Day 2-Sessions:

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Building Value for Liquid Biopsies in Oncology

Diagnostics Policy and the Impact on Innovation

Tumor Profiling to Clinical Action

Day 2-11:30 AM

Aris Baras, Regeneron Genetics Center
Opening Words by Session Chair
Frederic Pla, Genomic Health
Opening Words by Session Chair
Michael W. Nall, Biocept
Opening Words by Session Chair
Wolfgang Daum, Toma Biosciences
Opening Words by Session Chair

Day 2-11:45 AM

Kári Stefánsson, deCODE Genetics
Murali Krishna Prahalad, Epic Sciences
Actionable, Accurate and Accessible Liquid Biopsy
Louis Jacques, ADVI
Francisco M. De La Vega, Stanford University School of Medicine

Day 2-12:00 PM

George Yancopoulos, Regeneron Laboratories
Geoff Otto, Foundation Medicine
Development and Analytic Validation of a ctDNA Genomic Profiling Assay
Bonnie Anderson, Veracyte
Derrick Haslem, Intermountain Healthcare

Day 2- 12:15 PM

Richard Scheller, 23andMe
Paul Beresford, Biodesix
Discovering, Developing, Validating and Commercializing Liquid Biopsy Tests in Oncology
Q&AJoseph Tam, DiagCor

Day 2- 12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 2-Sessions:

The Secret to Wellness is Science

Beyond Genomics for Predicting Patient Response

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Achieving Accurate NGS Test Results


Day 2-1:30 PM

Lee Hood, Providence Health
Opening Words by Session Chair
Parker Cassidy, Mitra Biotech
Opening Words by Session Chair
Matt McLoughlin, Scientist.com
New Standard for Procuring Human Biospecimens
Russell Garlick, SeraCare
Opening Words by Session Chair

Day 2-1:45 PM

Jennifer Lovejoy, Arivale
Raanan Berger, Sheba Medical Center
Shiva Krupa, Biogen
Risks of Human Biospecimen Acquisition – Industry Perspective
Gregory Tsongalis, Dartmouth College
QC: Where the Rubber Meets the Road

Day 2-2:00 PM

Gil Omenn, University of Michigan
Udayan Guha, NIH
Brian Raudenbush, Boehringer Ingelheim Pharmaceuticals, Inc.
Challenges of Human Biospecimen Acquisition – Industry Perspective
Dara Aisner, University of Colorado School of Medicine
Confronting and Mitigating Pre-Analytic Variability

Day 2-2:15 PM

Q&AChristine A. Iacobuzio-Donahue, Memorial Sloan Kettering Cancer Center
Q&A
Q&A
Day 2-Sessions:

Immunotherapy: Immuno-checkpoint Inhibitors & Beyond

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

How to Make Rx-Dx Alliances Work

Scaling the 26-Hour Genome

Day 2-2:30 PM

Irv Weissman, Stanford School of Medicine
Opening Words by Session Chair
Walter Koch, Roche Molecular Systems, Inc.
Opening Words by Session Chair
Myla Lai-Goldman, GeneCentric Diagnostics
Words by Session Co-Chair
Pieter van Rooyen, Edico Genome
Opening Words by Session Chair

Day 2-2:45 PM

Jeffrey Bluestone, Parker Institute for Cancer Immunotherapy
Hacking Cancer with the Immune System
Helmy Eltoukhy , Guardant Health
Liquid Biopsy Applications and New Horizons
Eric Lai, Takeda
Words by Session Co-Chair
Dawn Barry, Illumina

Day 2-3:00 PM

Andrew Allen, Gritstone Oncology
Exploiting Mutations as Targets for the Immune System
Janine McMurdie, Agena Bioscience
Ultrasensitive Somatic Mutation Detection in cfDNA
Peter Collins, Premaitha Health
David Dimmock, Rady Children’s Hospital – San Diego

Day 2- 3:15 PM

Q&A
Q&A
Q&A
Q&A

Day 2- 3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

The Economics of Bringing Precision Medicine to the Clinic

Integrating Precision Medicine: Technical Challenges and Solutions

Progress in Improving the Evidence Base and Insurer Coverage

Day 2-4:00 PM

Brian Kelly, Quintiles
Paying for Precision Medicine: Perspectives from Other Countries
Eric Dishman, National Institutes of Health
Opening Words by Session Chair
Kathryn Phillips, UCSF
Reimbursement for Multigene Tests: The Good, The Bad, and The Ugly
Matthew McManus, Asuragen
Challenges to Creating Diagnostic Tests Across the Entire Genome

Day 2-4:15 PM

George Poste, Arizona State University
Opening Words by Session Chair
Lita M. Proctor, Human Microbiome Project
Joe Selby, PCORI
Patient-Centered Outcomes Research – in Support of Personalized Care
Track 4 Closing for Day 2

Day 2-4:30 PM

Roy Beveridge, Humana
David Glazer, Google
Patricia A. Deverka, American Institutes for Research
Pursuing Clinical Utility for Multi-Gene Tests and Genome-Scale Testing

Day 2-4:45 PM

Shari M. Ling, Centers for Medicare and Medicaid Services (CMS)
Gregory C. Simon, White House Cancer Moonshot Task Force
Q&A

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3

Day 2- 5:15 PM

Track 1 Closing for Day 2

Track 2 Closing for Day 2

  
Day 3

Time

Track 1

Track 2

Track 3

Track 4

Day 3-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 3-Sessions:

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Developing Successful Predictive Clinical Biomarkers

Day 3-8:00 AM

Jason Myers, ArcherDX
Opening Words by Session Chair
Ann Kapoun, Oncomed Pharma
Opening Words by Session Chair

Day 3-8:15 AM

Long Phi Le, Harvard Medical School
Mitch Raponi, Clovis Oncology

Day 3-8:30 AM

A. John Iafrate, Mass General
Terence Rhodes, Intermountain Healthcare
Current Immunotherapy Biomarkers and Future Directions
Neda Pakdaman, Stanford Medicine
Genetic Risk Assessment and Pharmacogenomics in Primary Care: A Pilot

Day 3-8:45 AM

Q&A
Carolyn Compton, National Biomarker Development Alliance
Developing Clinically Important (and Useful) Oncology Biomarkers: Challenges and Solutions
Jeffrey R. Luber, Good Start Genetics
Preconception Precision Testing: An Ounce of Prevention
Day 3-Sessions:

Precision Medicine Patent Law Update

Genetic Testing In Healthy Population

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Day 3-9:00 AM

Catherine Polizzi, Morrison & Foerster
Opening Words by Session Chair
Randy Scott, Invitae Corporation
Opening Words by Session Chair
Zaher Nahle, Solve ME/CFS Initiative
Opening Words by Session Chair

Day 3-9:15 AM

Michael Shuster, Fenwick & West
Robert C. Green, G2P
Genomic Sequencing in Healthy Individuals
Andreas Kogelnik, Open Medicine Institute (OMI)
Day 3-Sessions:

Biobanking Your Future

Genetic Testing In Healthy Population - Session Continued

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Continued

Day 3-9:30 AM

Nazneen Aziz, Kaiser Permanente
Role of Biobanks in Precision Medicine
Jordan Shlain, Private Medical
The Intersection of Primary Care & Genomics
Carol Head, Solve ME/CFS Initiative

Day 3-9:45 AM

Sumitra Muralidhar, VA
The Million Veteran Program: A Mega-Biobank for Precision Medicine
Justin Kao, Helix
The Future of Personal Genomics for All
Q&A

Day 3-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Complementary use of Digital PCR and NGS in Cancer Liquid Biopsy

Advancing the Clinic with Emerging NGS Technologies

Rare Disease Drug Development in Precision Medicine

How Immuno-oncology Saved My Life: A Patient’s Perspective

Day 3-10:30 AM

George Karlin-Neumann, Bio-Rad
Opening Words by Session Chair
Allison Ballmer, Roche
Opening Words by Session Chair
Mary Dixon Drake, Innovenn, Inc.
Opening Words by Session Chair
Andrew Schorr, Patient Power LLC
Opening Words by Session Chair

Day 3-10:45 AM

Lao Saal, SAGA Diagnostics AB
Tumor Heterogeneity and Circulating Tumor DNA Cancer Monitoring
Serge Saxonov, 10X Genomics
Marc Walton, Janssen
Natural History: Essential for Developing Rare Disease Therapies
Esther Schorr, Patient Power LLC

Day 3-11:00 AM

Isaac Garcia-Murillas, Institute of Cancer Research-UK
Prediction of Clinical Outcomes in Breast Cancer with ctDNA
Stefan Roever, Genia
Frank Czerwiec, Otsuka
Overcoming Data Challenges in Rare Disease Trials
Donald Stranathan, Patient Advocate

Day 3-11:15 AM

Lauren Ritterhouse, Harvard Medical School
Plasma cfDNA Mutation Detection in EGFR-Mutated Lung Cancer
Stephen Turner, Pacific Biosciences
Stephane Budel, DeciBio Consulting
Q&A
Lisa Goldman, Patient Advocate
Day 3-Sessions:

Expanding the Reach of Genomic Analysis

Clinical Trials in Immuno-therapy

Patient Power: The Changing Role of Individuals

Medical Devices and IoT: the Bridge to the Phenotype

Day 3-11:30 AM

Deanna Church, 10x Genomics
Opening Words by Session Chair
Patrice Hugo, Q2 Solutions
Opening Words by Session Chair
Cliff Reid, Genos Research
Opening Words by Session Chair
Sanjay Joshi, Dell EMC Emerging Technologies
Opening Words by Session Chair

Day 3-11:45 AM

Hanlee Ji, Stanford
Single Molecule and Cell Genomic and Immunologic Determinants of Cancer
Jonathan D. Cheng, Merck
Paul Billings, PlumCare LLC
Amer Haider, Doctella

Day 3-12:00 PM

Pui-Yan Kwok, UCSF
De novo Assembled Genomes for Full Genome Analysis
Samir N. Khleif, Augusta University
Linda Avey, Curious
Todd Gray, autonomous_ID

Day 3-12:15 PM

Q&A
James Novotny, Bristol-Myers Squibb
Jill Hagenkord, Color Genomics
Ashwin Pushpala, Sano
Manoj Dadlani, CosmosID

Day 3-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 3-Sessions:

CRISPR Technology – How It Has Changed Biological Research

Pathogen Specific Biologics for Infectious Diseases

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Podium Presentations

Day 3-1:30 PM

Jennifer Doudna, Berkeley
The Genome Engineering Revolution
Steven J. Projan, MedImmune
Opening Words by Session Chair
Ida Sim, UCSF
Opening Words by Session Chair
Steven Lynum, Panasonic Healthcare
Celebrating 50 Years in the Life Sciences

Day 3-1:45 PM

Shawn Shafer, MilliporeSigma
High Throughput Knockout Screening with CRISPR
René Russo, Arsanis
Targeted Prevention: The Future for Infectious Diseases
Sumbul Ahmad Desai, SHC
Ryan Witt, Immix BioPharma, Inc.
Pricing’s Looming Effect on I/O & PM

Day 3-2:00 PM

Jonathan S. Weissman, HHMI/UCSF
Controlling Gene Expression with CRISPRi and CRISPRa
Fred C. Tenover, Stanford University
Molecular Diagnostics: Patient Care and Clinical Trials
Ryan Howard, iBeat

Fireside Chat

Commercial Success to IPO: iRhythm CEO Interview
Casper de Clercq, Norwest Venture Partners

Day 3-2:15 PM

Q&A
David W. Martin, AvidBiotics Corp.
The Why and How of Pathogen-Specific Biologics
Q&A
Kevin King, iRythm Technologies
Day 3-Sessions:

NGS: Implementing a Clinical Workflow for All Constituents

Health Systems as Translational Research Partners

Track 3 Closing for Day 3Track 4 Closing for Day 3

Day 3-2:30 PM

Matthew Tindall, Omicia
Scaling Clinical NGS: From Panels to Exomes to WGS
Walter "Buzz" Stewart, Sutter Health
Opening Words by Session Chair

Day 3-2:45 PM

Kerry Kingham, Stanford
Genetic Counseling in the Clinic: Navigating and Translating Complex Results for the Patient
Joshua N. Liberman, Sutter Health
Precision Care for MS: Making It Work

Day 3-3:00 PM

Craig Parman, Bluebee
Bringing NGS Analytics from Research to the Clinic
Gregory J. Tranah, Sutter Health
Precision Medicine: Making It Work on Scale

Day 3-3:15 PM

Q&AQ&A

Day 3-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Companion Diagnostics: Where is the Incentive?

Company Competition Finals

TOP three finalists present to a VC panel and the audience
MC: Sheldon Schuster

Day 3-4:00 PM

Ed Winnick, GenomeWeb
Opening Words by Session Chair
Finalist 1

Day 3-4:15 PM

Mya Thomae, Illumina
Finalist 2

Day 3-4:30 PM

Sheila D. Walcoff, Goldbug Strategies
Finalist 3

Day 3-4:45 PM

Karen A. Heichman, ARUP
Winner is selected by panel of Judges
Day 3-Sessions:

The Global Alliance for Genomics and Health

Track 2 Closing for Day 3

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3

Time

Track 1

Track 2

Track 3

Track 4

Day 1

Day 1-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 1-8:00 AM


Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words
Track 1 Broadcast: Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words

Day 1-8:15 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients

Day 1-8:30 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Continued
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Continued

Company Competition Semi-Finals


Andrew Kurtz, NCI SBIR
Day 1-Sessions:

Immunotherapy: Emerging Applications and Therapies

Enabling Clinical-Grade NGS Testing

Company Competition Semi-Finals Continued

Day 1-8:45 AM

James Allison, MD Anderson Cancer Center
Opening Words by Session Chair
Sean Scott, Qiagen
Enabling Clinical-Grade NGS Testing “Dry Lab” Capabilities in Oncology
Abogen

Day 1-9:00 AM

Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immuno-oncology
Personalized Medicine - The Cinderella Story of Venture Investments?
Mara Aspinall, Genepeeks
Opening Words by Session Chair
Accelerated Medical Diagnostics

Day 1-9:15 AM

Debbie Law, Jounce Therapeutics
Developing JTX-2011 ICOS Agonist: A Translational Approach
Alexis Borisy, Third Rock Ventures
AccuraGen

Day 1-9:30 AM

James H. Godsey, Thermo Fisher Scientific
Addressing Immuno-oncology Research Challenges for Predictive Biomarkers
Andrew J. Schwab, 5AM Ventures
biomaRx

Day 1-9:45 AM

Q&A
Lindy Morris Fishburne, Breakout Labs
Cernostics

Day 1-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Issues and Challenges of Immunotherapy

The Value of Data Sharing

Company Competition Semi-Finals Continued

Emerging Infections: Tracking, Testing and Public Health Response

Day 1-10:30 AM

Lawrence Corey, Fred Hutchinson
Opening Words by Session Chair
John Leite, Illumina
John Shon, Illumina
Words by Session Co-Chair
Congenica Ltd.
Steve Miller, UCSF
Opening Words by Session Chair

Day 1-10:45 AM

Steve Harr, Juno Therapeutics
Lincoln Nadauld, Intermountain Healthcare
Sharon Terry, Genetic Alliance
CloudMedx
John Hackett, Abbott Laboratories
Challenges Associated With Development of Diagnostics to Emerging Agents

Day 1-11:00 AM

Ronald A. DePinho, MD Anderson Cancer Center
Juli Klemm, National Cancer Institute
Kathy Giusti, Multiple Myeloma Research Foundation
DName-iTDongxiang Xia, California Depart. of Public Health
Emerging Viral Infections: Lab Response

Day 1-11:15 AM

Crystal L. Mackall, Stanford University
Robert Nussbaum, Invitae
Gritstone Oncology
Q&A
Day 1-Sessions:

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Understanding Human Health and Diseases at the Individual Level

Company Competition Semi-Finals Continued

An Update on the Cancer Moonshot Blood Profiling Atlas

Day 1-11:30 AM

Brad Gray, NanoString Technologies
Opening Words by Session Chair
Euan Ashley, Stanford
Opening Words by Session Chair
Inanovate
Bruce Press, Seven Bridges
Opening Words by Session Chair

Day 1-11:45 AM

Kenneth Emancipator, Merck
Richard Chen, Personalis
Precision Medicine for Immuno-Oncology: Personalized Cancer Vaccines and Diagnostics
Inmedix
Howard I. Scher, Memorial Sloan Kettering Cancer Center

Day 1-12:00 PM

Daniel Chen, Genentech
Jessica Mega, Verily
JBS Science
Geoff Otto, Foundation Medicine

Day 1-12:15 PM

Steven Averbuch, Bristol-Myers Squibb
Sowmi Utiramerur, Stanford Health Care
KIYATEC
Q&A

Day 1-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 1-Sessions:

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Company Competition Semi-Finals Continued

Reaching New Heights in Sequencing

Day 1-1:30 PM

Chris Cournoyer, N-of-One
Opening Words by Session Chair
John Ryals, Metabolon
Metabolomics and Its Role in Precision Medicine
Sequence BioMirna Jarosz, IDT
Methods for Accurate Variant Detection in cfDNA

Day 1-1:45 PM

Donald L. (Skip) Trump, Inova Schar Cancer Institute.
Emily Leproust, Twist Bioscience
Rewriting DNA Synthesis
Standigm
Alexander Bisignano, Phosphorous
A Distributed Clinical Data Network

Day 1-2:00 PM

Thomas D. Brown, Swedish Cancer Institute
Gautam Kollu, Illumina
Diagnosing genetic diseases using Whole Genome Sequencing
Two Pore Guys
Frederick Lee Baehner, Genomic Health
Where Value Based Care and Precision Medicine Converge

Day 1-2:15 PM

Q&A
Summerpal Kahlon, Oracle
Intelligent Care: Translating Data into Insight
Vitatex
Kaja Milanowska, Ardigen SA
Artificial Intelligence for Personalized Medicine
Day 1-Sessions:

Importance of Standardized Assays for Precision Medicine

Clinical Applications of ctDNA in Cancer Management

Emerging Technologies

Learnings from Precision Medicine Centers

Day 1-2:30 PM

Jeffrey Edward Miller, Invivoscribe
Opening Words by Session Chair
Clive Morris, Inivata
The Future of ctDNA
Fabien Beckers, Arterys
Adding Medical Imaging Features to Precision Medicine
Berta Strulovici, The Israel National Center for PM
Integrated Technological Platforms in Israel

Day 1-2:45 PM

Bradley Patay, Genection
Importance of Design Controlled Assays in Hematopathology
Nitzan Rosenfeld, Inivata
Targeted Deep Sequencing of Circulating Tumor DNA
Stephen J. Matlin, Life Length
Telomeres: Unlocking The Aging Code
Mathias Uhlen, SciLifeLab
The SCAPIS SciLifeLab Wellness Profiling Program

Day 1-3:00 PM

Mark Levis, Johns Hopkins University
Acute Myeloid Leukemia: Bringing Order Out of Chaos
Ramaswamy Govindan, Washington University School of Medicine
ctDNA in the Treatment of Lung Cancer- Opportunities and Challenges
Stephen Quake, Stanford University
Precision Measurements in Biology
Vandhana Krishnan, Stanford University
Assessment of Variant Calling Pipelines for Clinical Diagnosis

Day 1-3:15 PM

Q&A
Q&A
Nick Lench, Congenica
Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes
Cuiping Pan, VA Palo Alto
Million Veteran Program Builds a Mega-biobank for Human Disease Research

Day 1-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Leveraging Chip Technologies for Healthcare

Moving Precision Medicine to Precision Health

Podium Presentations

Adoption of Precision Medicine: Hereditary Cancer

Day 1-4:00 PM

Roeland Huys, imecHarold L. Paz, Aetna
Opening Words by Session Chair
Boris Hayete, GNS Healthcare
Parkinson’s Disease: in Search of Predictors of Progression
Taylor Sittler, Color Genomics
Opening Words by Session Chair

Day 1-4:15 PM

Clinical Next-Generation Sequencing for Infectious Disease Diagnosis


Charles Chiu, UCSF
Opening Words by Session Chair
Lincoln Nadauld, Intermountain Healthcare
Paul Docherty, Hologic
Diagnostic: Pharma Relationships in CDx Development
Kevin Hughes, Harvard Medical School

Day 1-4:30 PM

Robert Schlaberg, IDbyDNA Inc.
Dx Application of NGS Tests for Infectious Diseases
Amy Burd, LLS
George Vasmatzis, Mayo Clinic
Detecting Rearrangements Using NGS and Applications to Biomarker Discovery
Theodora Ross, UT Southwestern Medical Center

Day 1-4:45 PM

Heike Sichtig, US Food and Drug Administration
FDA’s Role and Tools for ID-NGS Diagnostics
Harlan Krumholz, Yale School of Medicine
Fred Streitz, Lawrence Livermore National Laboratory
Accelerating Cancer Research with Extreme Scale Computing
Heather Hampel, The Ohio State University Wexner Medical Center

Day 1- 5:00 PM

Mickey Kertesz, Karius, Inc.
Infectious Disease Diagnostics for the Genomic Era

An Update on the Cancer Moonshot and Brain Government Initiatives


Joshua Gordon, National Institute of Mental Health
Update from the NIMH: Precision Medicine and the BRAIN Initiative

Day 1- 5:15 PM

Track 1 Closing for Day 1

Track 2 Closing for Day 1

Track 3 Closing for Day 1Track 4 Closing for Day 1
Day 2

Time

Track 1

Track 2

Track 3

Track 4

Day 2-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 2-Sessions:

How Scientific Wellness Will Transform Healthcare

An Update on the Cancer Moonshot and Brain Government Initiatives (Cont.)

Day 2-7:30 AM

Lee Hood, Providence Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force
Walking On The Moon: Reflections

Podium Presentations

Peter Donnelly, Oxford University
Learning the Human Wiring Diagram from Genomics

Day 2-7:45 AM

Rodney F. Hochman, Providence St. Joseph Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force- Continued
Walking On The Moon: Reflections
Eric Kowack, Ignyta
An Innovative Approach For Dx-Driven Oncology Trials

Unlocking Real-World Clinical Data


Sean Scott, Qiagen
Integrating NGS-based Test Results with Clinical Outcomes Data to Improve Physician Decision Support
Day 2-Sessions:

How Molecular Subtyping Can Aid Clinical Drug Development

Population Precision Medicine
Presented by India Hook-Barnard

Podium Presentations Continued

Unlocking Real-World Clinical Data continued

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:30 AM

How to Commercialize Technologies That Advance PM


Alex De Winter, GE Ventures
Fireside Chat
Robert A. Hiatt, UCSF

Driving Value for Genomics Startups


Amanda Cashin, Illumina Accelerator
George Komatsoulis, CancerLinQ
Big Data in Cancer Care

Day 2-8:45 AM

Mark Fischer-Colbrie, Labcyte
Fireside Chat
Q&A
Trevor Levin, UrologyDx
Nick Conley, Epibiome
Phong Le, HPE
Preparing for the Next Step in Genomic Analysis
Day 2-Sessions:

New Healthcare Paradigm from the $100 Genome

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Enabling Advances in Human Microbiome Research

CIAPM: Accelerating Precision Medicine Advances in California

Day 2-9:00 AM

Yiwu He, BGI
Implications of $100 Whole Genome Sequencing
Assaf Halevy, 2bPrecise
Opening Words by Session Chair
Nick Conley, Epibiome
Opening Words by Session Chair
Elizabeth Baca, Governor's Office of Planning and Research
Opening Words by Session Chair

Day 2-9:15 AM

Q&A
Holli Hutcheson Dilks, Sarah Cannon Research InstituteDavid Mills, UC Davis
Restoring Ecosystem Function in the Infant Microbiome
Uta Grieshammer, CIAPM

Day 2-9:30 AM

Rade Drmanac, Complete Genomics, Inc. (a BGI company)
Efficient WGS as Foundation for Precision Medicine
John Mattison, Kaiser PermanenteSusan Lynch, Siolta Therapeutics
The Gut Microbiome and Childhood Allergic Asthma
Nicholas Anderson, UC Davis
Rowan Chapman, Johnson & Johnson Innovation - California

Day 2- 9:45 AM

Q&A
Amy Urban, UPMC
Joel Diamond, 2bPrecise
Lihi Segal , DayTwo
Personalized Nutrition Using Gut Microbiome and Clinical Data
Brennan Spiegel, Cedars-Sinai
Olena Morozova, UCSC

Day 2-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

How To Engage Community Oncologists in Precision Medicine

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Emerging Themes in the Human Microbiome

Data Sharing: Patient Rights and Privacy

Day 2-10:30 AM

Lincoln Nadauld, Intermountain Healthcare
Laurence Marton, PMWC 2014 Session Chair
Words by Session Co-Chair
Atul Butte, UCSF
Driving Disease Understanding and Treatment via a Centralized Data Warehouse
Michael Fischbach, California Institute for Quantitative Biosciences (QB3)
Opening Words by Session Chair
William Knox Carey, Genecloud
Opening Words by Session Chair

Day 2-10:45 AM

Tim Collins, Scripps Health
Diane Wuest, GNS Healthcare
Unlocking Precise Knowledge within Complex Data via Causal Machine Learning
Erica Sonnenburg, Stanford University School of Medicine
Sharon Terry, Genetic Alliance

Day 2-11:00 AM

Edmund Tai, PAMF
Marylyn D. Ritchie, Geisinger Health System
Defining Disease in a Vast Sea of Phenotypes
Justin Sonnenburg, Stanford University School of Medicine
Lucila Ohno-Machado, University of California San Diego

Day 2-11:15 AM

Kevin Knopf, Cancer Commons
Q&A
Lita M. Proctor, Human Microbiome Project
Sandra Soo-Jin Lee, Stanford University
Day 2-Sessions:

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Building Value for Liquid Biopsies in Oncology

Diagnostics Policy and the Impact on Innovation

Tumor Profiling to Clinical Action

Day 2-11:30 AM

Aris Baras, Regeneron Genetics Center
Opening Words by Session Chair
Frederic Pla, Genomic Health
Opening Words by Session Chair
Michael W. Nall, Biocept
Opening Words by Session Chair
Wolfgang Daum, Toma Biosciences
Opening Words by Session Chair

Day 2-11:45 AM

Kári Stefánsson, deCODE Genetics
Murali Krishna Prahalad, Epic Sciences
Actionable, Accurate and Accessible Liquid Biopsy
Louis Jacques, ADVI
Francisco M. De La Vega, Stanford University School of Medicine

Day 2-12:00 PM

George Yancopoulos, Regeneron Laboratories
Geoff Otto, Foundation Medicine
Development and Analytic Validation of a ctDNA Genomic Profiling Assay
Bonnie Anderson, Veracyte
Derrick Haslem, Intermountain Healthcare

Day 2- 12:15 PM

Richard Scheller, 23andMe
Paul Beresford, Biodesix
Discovering, Developing, Validating and Commercializing Liquid Biopsy Tests in Oncology
Q&AJoseph Tam, DiagCor

Day 2- 12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 2-Sessions:

The Secret to Wellness is Science

Beyond Genomics for Predicting Patient Response

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Achieving Accurate NGS Test Results


Day 2-1:30 PM

Lee Hood, Providence Health
Opening Words by Session Chair
Parker Cassidy, Mitra Biotech
Opening Words by Session Chair
Matt McLoughlin, Scientist.com
New Standard for Procuring Human Biospecimens
Russell Garlick, SeraCare
Opening Words by Session Chair

Day 2-1:45 PM

Jennifer Lovejoy, Arivale
Raanan Berger, Sheba Medical Center
Shiva Krupa, Biogen
Risks of Human Biospecimen Acquisition – Industry Perspective
Gregory Tsongalis, Dartmouth College
QC: Where the Rubber Meets the Road

Day 2-2:00 PM

Gil Omenn, University of Michigan
Udayan Guha, NIH
Brian Raudenbush, Boehringer Ingelheim Pharmaceuticals, Inc.
Challenges of Human Biospecimen Acquisition – Industry Perspective
Dara Aisner, University of Colorado School of Medicine
Confronting and Mitigating Pre-Analytic Variability

Day 2-2:15 PM

Q&AChristine A. Iacobuzio-Donahue, Memorial Sloan Kettering Cancer Center
Q&A
Q&A
Day 2-Sessions:

Immunotherapy: Immuno-checkpoint Inhibitors & Beyond

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

How to Make Rx-Dx Alliances Work

Scaling the 26-Hour Genome

Day 2-2:30 PM

Irv Weissman, Stanford School of Medicine
Opening Words by Session Chair
Walter Koch, Roche Molecular Systems, Inc.
Opening Words by Session Chair
Myla Lai-Goldman, GeneCentric Diagnostics
Words by Session Co-Chair
Pieter van Rooyen, Edico Genome
Opening Words by Session Chair

Day 2-2:45 PM

Jeffrey Bluestone, Parker Institute for Cancer Immunotherapy
Hacking Cancer with the Immune System
Helmy Eltoukhy , Guardant Health
Liquid Biopsy Applications and New Horizons
Eric Lai, Takeda
Words by Session Co-Chair
Dawn Barry, Illumina

Day 2-3:00 PM

Andrew Allen, Gritstone Oncology
Exploiting Mutations as Targets for the Immune System
Janine McMurdie, Agena Bioscience
Ultrasensitive Somatic Mutation Detection in cfDNA
Peter Collins, Premaitha Health
David Dimmock, Rady Children’s Hospital – San Diego

Day 2- 3:15 PM

Q&A
Q&A
Q&A
Q&A

Day 2- 3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

The Economics of Bringing Precision Medicine to the Clinic

Integrating Precision Medicine: Technical Challenges and Solutions

Progress in Improving the Evidence Base and Insurer Coverage

Day 2-4:00 PM

Brian Kelly, Quintiles
Paying for Precision Medicine: Perspectives from Other Countries
Eric Dishman, National Institutes of Health
Opening Words by Session Chair
Kathryn Phillips, UCSF
Reimbursement for Multigene Tests: The Good, The Bad, and The Ugly
Matthew McManus, Asuragen
Challenges to Creating Diagnostic Tests Across the Entire Genome

Day 2-4:15 PM

George Poste, Arizona State University
Opening Words by Session Chair
Lita M. Proctor, Human Microbiome Project
Joe Selby, PCORI
Patient-Centered Outcomes Research – in Support of Personalized Care
Track 4 Closing for Day 2

Day 2-4:30 PM

Roy Beveridge, Humana
David Glazer, Google
Patricia A. Deverka, American Institutes for Research
Pursuing Clinical Utility for Multi-Gene Tests and Genome-Scale Testing

Day 2-4:45 PM

Shari M. Ling, Centers for Medicare and Medicaid Services (CMS)
Gregory C. Simon, White House Cancer Moonshot Task Force
Q&A

Day 2- 5:00 PM

Lotte Steuten, Fred Hutchinson Cancer Research Center

How AI Will Humanize Clinical Diagnostics


Esteban Czwan, Sophia Genetics
Track 3 Closing for Day 2

Day 2- 5:15 PM

Track 1 Closing for Day 2

Track 2 Closing for Day 2

Day 3

Time

Track 1

Track 2

Track 3

Track 4

Day 3-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 3-Sessions:

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Developing Successful Predictive Clinical Biomarkers

Day 3-8:00 AM

Jason Myers, ArcherDX
Opening Words by Session Chair
Ann Kapoun, Oncomed Pharma
Opening Words by Session Chair

Day 3-8:15 AM

Long Phi Le, Harvard Medical School
Mitch Raponi, Clovis Oncology

Day 3-8:30 AM

A. John Iafrate, Mass General
Terence Rhodes, Intermountain Healthcare
Current Immunotherapy Biomarkers and Future Directions
Neda Pakdaman, Stanford Medicine
Genetic Risk Assessment and Pharmacogenomics in Primary Care: A Pilot

Day 3-8:45 AM

Q&A
Carolyn Compton, National Biomarker Development Alliance
Developing Clinically Important (and Useful) Oncology Biomarkers: Challenges and Solutions
Jeffrey R. Luber, Good Start Genetics
Preconception Precision Testing: An Ounce of Prevention
Day 3-Sessions:

Precision Medicine Patent Law Update

Genetic Testing In Healthy Population

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Day 3-9:00 AM

Catherine Polizzi, Morrison & Foerster
Opening Words by Session Chair
Randy Scott, Invitae Corporation
Opening Words by Session Chair
Zaher Nahle, Solve ME/CFS Initiative
Opening Words by Session Chair

Day 3-9:15 AM

Michael Shuster, Fenwick & West
Robert C. Green, G2P
Genomic Sequencing in Healthy Individuals
Andreas Kogelnik, Open Medicine Institute (OMI)
Day 3-Sessions:

Biobanking Your Future

Genetic Testing In Healthy Population - Session Continued

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Continued

Day 3-9:30 AM

Nazneen Aziz, Kaiser Permanente
Role of Biobanks in Precision Medicine
Jordan Shlain, Private Medical
The Intersection of Primary Care & Genomics
Carol Head, Solve ME/CFS Initiative

Day 3-9:45 AM

Sumitra Muralidhar, VA
The Million Veteran Program: A Mega-Biobank for Precision Medicine
Justin Kao, Helix
The Future of Personal Genomics for All
Q&A

Day 3-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Complementary use of Digital PCR and NGS in Cancer Liquid Biopsy

Advancing the Clinic with Emerging NGS Technologies

Rare Disease Drug Development in Precision Medicine

How Immuno-oncology Saved My Life: A Patient’s Perspective

Day 3-10:30 AM

George Karlin-Neumann, Bio-Rad
Opening Words by Session Chair
Allison Ballmer, Roche
Opening Words by Session Chair
Mary Dixon Drake, Innovenn, Inc.
Opening Words by Session Chair
Andrew Schorr, Patient Power LLC
Opening Words by Session Chair

Day 3-10:45 AM

Lao Saal, SAGA Diagnostics AB
Tumor Heterogeneity and Circulating Tumor DNA Cancer Monitoring
Serge Saxonov, 10X Genomics
Marc Walton, Janssen
Natural History: Essential for Developing Rare Disease Therapies
Esther Schorr, Patient Power LLC

Day 3-11:00 AM

Isaac Garcia-Murillas, Institute of Cancer Research-UK
Prediction of Clinical Outcomes in Breast Cancer with ctDNA
Stefan Roever, Genia
Frank Czerwiec, Otsuka
Overcoming Data Challenges in Rare Disease Trials
Donald Stranathan, Patient Advocate

Day 3-11:15 AM

Lauren Ritterhouse, Harvard Medical School
Plasma cfDNA Mutation Detection in EGFR-Mutated Lung Cancer
Stephen Turner, Pacific Biosciences
Stephane Budel, DeciBio Consulting
Q&A
Lisa Goldman, Patient Advocate
Day 3-Sessions:

Expanding the Reach of Genomic Analysis

Clinical Trials in Immuno-therapy

Patient Power: The Changing Role of Individuals

Medical Devices and IoT: the Bridge to the Phenotype

Day 3-11:30 AM

Deanna Church, 10x Genomics
Opening Words by Session Chair
Patrice Hugo, Q2 Solutions
Opening Words by Session Chair
Cliff Reid, Genos Research
Opening Words by Session Chair
Sanjay Joshi, Dell EMC Emerging Technologies
Opening Words by Session Chair

Day 3-11:45 AM

Hanlee Ji, Stanford
Single Molecule and Cell Genomic and Immunologic Determinants of Cancer
Jonathan D. Cheng, Merck
Paul Billings, PlumCare LLC
Amer Haider, Doctella

Day 3-12:00 PM

Pui-Yan Kwok, UCSF
De novo Assembled Genomes for Full Genome Analysis
Samir N. Khleif, Augusta University
Linda Avey, Curious
Todd Gray, autonomous_ID

Day 3-12:15 PM

Q&A
James Novotny, Bristol-Myers Squibb
Jill Hagenkord, Color Genomics
Ashwin Pushpala, Sano
Manoj Dadlani, CosmosID

Day 3-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 3-Sessions:

CRISPR Technology – How It Has Changed Biological Research

Pathogen Specific Biologics for Infectious Diseases

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Podium Presentations

Day 3-1:30 PM

Jennifer Doudna, Berkeley
The Genome Engineering Revolution
Steven J. Projan, MedImmune
Opening Words by Session Chair
Ida Sim, UCSF
Opening Words by Session Chair
Steven Lynum, Panasonic Healthcare
Celebrating 50 Years in the Life Sciences

Day 3-1:45 PM

Shawn Shafer, MilliporeSigma
High Throughput Knockout Screening with CRISPR
René Russo, Arsanis
Targeted Prevention: The Future for Infectious Diseases
Sumbul Ahmad Desai, SHC
Ryan Witt, Immix BioPharma, Inc.
Pricing’s Looming Effect on I/O & PM

Day 3-2:00 PM

Jonathan S. Weissman, HHMI/UCSF
Controlling Gene Expression with CRISPRi and CRISPRa
Fred C. Tenover, Stanford University
Molecular Diagnostics: Patient Care and Clinical Trials
Ryan Howard, iBeat

Fireside Chat

Commercial Success to IPO: iRhythm CEO Interview
Casper de Clercq, Norwest Venture Partners

Day 3-2:15 PM

Q&A
David W. Martin, AvidBiotics Corp.
The Why and How of Pathogen-Specific Biologics
Q&A
Kevin King, iRythm Technologies
Day 3-Sessions:

NGS: Implementing a Clinical Workflow for All Constituents

Health Systems as Translational Research Partners

Track 3 Closing for Day 3Track 4 Closing for Day 3

Day 3-2:30 PM

Matthew Tindall, Omicia
Scaling Clinical NGS: From Panels to Exomes to WGS
Walter "Buzz" Stewart, Sutter Health
Opening Words by Session Chair

Day 3-2:45 PM

Kerry Kingham, Stanford
Genetic Counseling in the Clinic: Navigating and Translating Complex Results for the Patient
Joshua N. Liberman, Sutter Health
Precision Care for MS: Making It Work

Day 3-3:00 PM

Craig Parman, Bluebee
Bringing NGS Analytics from Research to the Clinic
Gregory J. Tranah, Sutter Health
Precision Medicine: Making It Work on Scale

Day 3-3:15 PM

Q&AQ&A

Day 3-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Companion Diagnostics: Where is the Incentive?

Company Competition Finals

TOP three finalists present to a VC panel and the audience
MC: Sheldon Schuster

Day 3-4:00 PM

Ed Winnick, GenomeWeb
Opening Words by Session Chair
Finalist 1

Day 3-4:15 PM

Mya Thomae, Illumina
Finalist 2

Day 3-4:30 PM

Sheila D. Walcoff, Goldbug Strategies
Finalist 3

Day 3-4:45 PM

Karen A. Heichman, ARUP
Winner is selected by panel of Judges
Day 3-Sessions:

The Global Alliance for Genomics and Health

Track 2 Closing for Day 3

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3

Day 1

Time

Track 1

Track 2

Track 3

Track 4

Day 1-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 1-8:00 AM


Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words
Track 1 Broadcast: Tal Behar, PMWC Intl.
Euan Ashley, Stanford Clinical Genomics Service
Sam Hawgood, UCSF
Opening Words

Day 1-8:15 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients

Day 1-8:30 AM

Robert Califf, FDA
Keith Yamamoto, UCSF
Continued
Track 1 Broadcast: Robert Califf, FDA
Keith Yamamoto, UCSF
Continued

Company Competition Semi-Finals


Andrew Kurtz, NCI SBIR
Day 1-Sessions:

Immunotherapy: Emerging Applications and Therapies

Enabling Clinical-Grade NGS Testing

Company Competition Semi-Finals Continued

Day 1-8:45 AM

James Allison, MD Anderson Cancer Center
Opening Words by Session Chair
Sean Scott, Qiagen
Enabling Clinical-Grade NGS Testing “Dry Lab” Capabilities in Oncology
Abogen

Day 1-9:00 AM

Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immuno-oncology
Personalized Medicine - The Cinderella Story of Venture Investments?
Mara Aspinall, Genepeeks
Opening Words by Session Chair
Accelerated Medical Diagnostics

Day 1-9:15 AM

Debbie Law, Jounce Therapeutics
Developing JTX-2011 ICOS Agonist: A Translational Approach
Alexis Borisy, Third Rock Ventures
AccuraGen

Day 1-9:30 AM

James H. Godsey, Thermo Fisher Scientific
Addressing Immuno-oncology Research Challenges for Predictive Biomarkers
Andrew J. Schwab, 5AM Ventures
biomaRx

Day 1-9:45 AM

Q&A
Lindy Morris Fishburne, Breakout Labs
Cernostics

Day 1-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Issues and Challenges of Immunotherapy

The Value of Data Sharing

Company Competition Semi-Finals Continued

Emerging Infections: Tracking, Testing and Public Health Response

Day 1-10:30 AM

Lawrence Corey, Fred Hutchinson
Opening Words by Session Chair
John Leite, Illumina
John Shon, Illumina
Words by Session Co-Chair
Congenica Ltd.
Steve Miller, UCSF
Opening Words by Session Chair

Day 1-10:45 AM

Steve Harr, Juno Therapeutics
Lincoln Nadauld, Intermountain Healthcare
Sharon Terry, Genetic Alliance
CloudMedx
John Hackett, Abbott Laboratories
Challenges Associated With Development of Diagnostics to Emerging Agents

Day 1-11:00 AM

Ronald A. DePinho, MD Anderson Cancer Center
Juli Klemm, National Cancer Institute
Kathy Giusti, Multiple Myeloma Research Foundation
DName-iTDongxiang Xia, California Depart. of Public Health
Emerging Viral Infections: Lab Response

Day 1-11:15 AM

Crystal L. Mackall, Stanford University
Robert Nussbaum, Invitae
Gritstone Oncology
Q&A
Day 1-Sessions:

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Understanding Human Health and Diseases at the Individual Level

Company Competition Semi-Finals Continued

An Update on the Cancer Moonshot Blood Profiling Atlas

Day 1-11:30 AM

Brad Gray, NanoString Technologies
Opening Words by Session Chair
Euan Ashley, Stanford
Opening Words by Session Chair
Inanovate
Bruce Press, Seven Bridges
Opening Words by Session Chair

Day 1-11:45 AM

Kenneth Emancipator, Merck
Richard Chen, Personalis
Precision Medicine for Immuno-Oncology: Personalized Cancer Vaccines and Diagnostics
Inmedix
Howard I. Scher, Memorial Sloan Kettering Cancer Center

Day 1-12:00 PM

Daniel Chen, Genentech
Jessica Mega, Verily
JBS Science
Geoff Otto, Foundation Medicine

Day 1-12:15 PM

Steven Averbuch, Bristol-Myers Squibb
Sowmi Utiramerur, Stanford Health Care
KIYATEC
Q&A

Day 1-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 1-Sessions:

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Company Competition Semi-Finals Continued

Reaching New Heights in Sequencing

Day 1-1:30 PM

Chris Cournoyer, N-of-One
Opening Words by Session Chair
John Ryals, Metabolon
Metabolomics and Its Role in Precision Medicine
Sequence BioMirna Jarosz, IDT
Methods for Accurate Variant Detection in cfDNA

Day 1-1:45 PM

Donald L. (Skip) Trump, Inova Schar Cancer Institute.
Emily Leproust, Twist Bioscience
Rewriting DNA Synthesis
Standigm
Alexander Bisignano, Phosphorous
A Distributed Clinical Data Network

Day 1-2:00 PM

Thomas D. Brown, Swedish Cancer Institute
Gautam Kollu, Illumina
Diagnosing genetic diseases using Whole Genome Sequencing
Two Pore Guys
Frederick Lee Baehner, Genomic Health
Where Value Based Care and Precision Medicine Converge

Day 1-2:15 PM

Q&A
Summerpal Kahlon, Oracle
Intelligent Care: Translating Data into Insight
Vitatex
Kaja Milanowska, Ardigen SA
Artificial Intelligence for Personalized Medicine
Day 1-Sessions:

Importance of Standardized Assays for Precision Medicine

Clinical Applications of ctDNA in Cancer Management

Emerging Technologies

Learnings from Precision Medicine Centers

Day 1-2:30 PM

Jeffrey Edward Miller, Invivoscribe
Opening Words by Session Chair
Clive Morris, Inivata
The Future of ctDNA
Fabien Beckers, Arterys
Adding Medical Imaging Features to Precision Medicine
Berta Strulovici, The Israel National Center for PM
Integrated Technological Platforms in Israel

Day 1-2:45 PM

Bradley Patay, Genection
Importance of Design Controlled Assays in Hematopathology
Nitzan Rosenfeld, Inivata
Targeted Deep Sequencing of Circulating Tumor DNA
Stephen J. Matlin, Life Length
Telomeres: Unlocking The Aging Code
Mathias Uhlen, SciLifeLab
The SCAPIS SciLifeLab Wellness Profiling Program

Day 1-3:00 PM

Mark Levis, Johns Hopkins University
Acute Myeloid Leukemia: Bringing Order Out of Chaos
Ramaswamy Govindan, Washington University School of Medicine
ctDNA in the Treatment of Lung Cancer- Opportunities and Challenges
Stephen Quake, Stanford University
Precision Measurements in Biology
Vandhana Krishnan, Stanford University
Assessment of Variant Calling Pipelines for Clinical Diagnosis

Day 1-3:15 PM

Q&A
Q&A
Nick Lench, Congenica
Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes
Cuiping Pan, VA Palo Alto
Million Veteran Program Builds a Mega-biobank for Human Disease Research

Day 1-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 1-Sessions:

Leveraging Chip Technologies for Healthcare

Moving Precision Medicine to Precision Health

Podium Presentations

Adoption of Precision Medicine: Hereditary Cancer

Day 1-4:00 PM

Roeland Huys, imecHarold L. Paz, Aetna
Opening Words by Session Chair
Boris Hayete, GNS Healthcare
Parkinson’s Disease: in Search of Predictors of Progression
Taylor Sittler, Color Genomics
Opening Words by Session Chair

Day 1-4:15 PM

Clinical Next-Generation Sequencing for Infectious Disease Diagnosis


Charles Chiu, UCSF
Opening Words by Session Chair
Lincoln Nadauld, Intermountain Healthcare
Paul Docherty, Hologic
Diagnostic: Pharma Relationships in CDx Development
Kevin Hughes, Harvard Medical School

Day 1-4:30 PM

Robert Schlaberg, IDbyDNA Inc.
Dx Application of NGS Tests for Infectious Diseases
Amy Burd, LLS
George Vasmatzis, Mayo Clinic
Detecting Rearrangements Using NGS and Applications to Biomarker Discovery
Theodora Ross, UT Southwestern Medical Center

Day 1-4:45 PM

Heike Sichtig, US Food and Drug Administration
FDA’s Role and Tools for ID-NGS Diagnostics
Harlan Krumholz, Yale School of Medicine
Fred Streitz, Lawrence Livermore National Laboratory
Accelerating Cancer Research with Extreme Scale Computing
Heather Hampel, The Ohio State University Wexner Medical Center

Day 1- 5:00 PM

Mickey Kertesz, Karius, Inc.
Infectious Disease Diagnostics for the Genomic Era

An Update on the Cancer Moonshot and Brain Government Initiatives


Joshua Gordon, National Institute of Mental Health
Update from the NIMH: Precision Medicine and the BRAIN Initiative

Day 1- 5:15 PM

Track 1 Closing for Day 1

Track 2 Closing for Day 1

Track 3 Closing for Day 1Track 4 Closing for Day 1

Day 2

Time

Track 1

Track 2

Track 3

Track 4

Day 2-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 2-Sessions:

How Scientific Wellness Will Transform Healthcare

An Update on the Cancer Moonshot and Brain Government Initiatives (Cont.)

Day 2-7:30 AM

Lee Hood, Providence Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force
Walking On The Moon: Reflections

Podium Presentations

Peter Donnelly, Oxford University
Learning the Human Wiring Diagram from Genomics

Day 2-7:45 AM

Rodney F. Hochman, Providence St. Joseph Health
Fireside Chat
Greg C. Simon, White House Cancer Moonshot Task Force- Continued
Walking On The Moon: Reflections
Eric Kowack, Ignyta
An Innovative Approach For Dx-Driven Oncology Trials

Unlocking Real-World Clinical Data


Sean Scott, Qiagen
Integrating NGS-based Test Results with Clinical Outcomes Data to Improve Physician Decision Support
Day 2-Sessions:

How Molecular Subtyping Can Aid Clinical Drug Development

Population Precision Medicine
Presented by India Hook-Barnard

Podium Presentations Continued

Unlocking Real-World Clinical Data continued

Day 2-8:00 AM

Janusz Dutkowski, Data4Cure
Opening Words by Session Chair
Kirsten Bibbins-Domingo, UCSF
Opening Words by Session Chair
Amy Burd, LLS
Introducing a New Concept in AML
Amy Abernethy, Flatiron Health
Opening Words by Session Chair

Day 2-8:15 AM

Pallavi Sachdev, Eisai
Michael Snyder, Stanford
Carl Yamashiro, Arizona State University
Biomedical Diagnostics Education: A New Frontier
Cary Gross, Yale University
Early Insights from an Academic-Industry Collaboration

Day 2-8:30 AM

How to Commercialize Technologies That Advance PM


Alex De Winter, GE Ventures
Fireside Chat
Robert A. Hiatt, UCSF

Driving Value for Genomics Startups


Amanda Cashin, Illumina Accelerator
George Komatsoulis, CancerLinQ
Big Data in Cancer Care

Day 2-8:45 AM

Mark Fischer-Colbrie, Labcyte
Fireside Chat
Q&A
Trevor Levin, UrologyDx
Nick Conley, Epibiome
Phong Le, HPE
Preparing for the Next Step in Genomic Analysis
Day 2-Sessions:

New Healthcare Paradigm from the $100 Genome

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Enabling Advances in Human Microbiome Research

CIAPM: Accelerating Precision Medicine Advances in California

Day 2-9:00 AM

Yiwu He, BGI
Implications of $100 Whole Genome Sequencing
Assaf Halevy, 2bPrecise
Opening Words by Session Chair
Nick Conley, Epibiome
Opening Words by Session Chair
Elizabeth Baca, Governor's Office of Planning and Research
Opening Words by Session Chair

Day 2-9:15 AM

Q&A
Holli Hutcheson Dilks, Sarah Cannon Research InstituteDavid Mills, UC Davis
Restoring Ecosystem Function in the Infant Microbiome
Uta Grieshammer, CIAPM

Day 2-9:30 AM

Rade Drmanac, Complete Genomics, Inc. (a BGI company)
Efficient WGS as Foundation for Precision Medicine
John Mattison, Kaiser PermanenteSusan Lynch, Siolta Therapeutics
The Gut Microbiome and Childhood Allergic Asthma
Nicholas Anderson, UC Davis
Rowan Chapman, Johnson & Johnson Innovation - California

Day 2- 9:45 AM

Q&A
Amy Urban, UPMC
Joel Diamond, 2bPrecise
Lihi Segal , DayTwo
Personalized Nutrition Using Gut Microbiome and Clinical Data
Brennan Spiegel, Cedars-Sinai
Olena Morozova, UCSC

Day 2-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

How To Engage Community Oncologists in Precision Medicine

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Emerging Themes in the Human Microbiome

Data Sharing: Patient Rights and Privacy

Day 2-10:30 AM

Lincoln Nadauld, Intermountain Healthcare
Laurence Marton, PMWC 2014 Session Chair
Words by Session Co-Chair
Atul Butte, UCSF
Driving Disease Understanding and Treatment via a Centralized Data Warehouse
Michael Fischbach, California Institute for Quantitative Biosciences (QB3)
Opening Words by Session Chair
William Knox Carey, Genecloud
Opening Words by Session Chair

Day 2-10:45 AM

Tim Collins, Scripps Health
Diane Wuest, GNS Healthcare
Unlocking Precise Knowledge within Complex Data via Causal Machine Learning
Erica Sonnenburg, Stanford University School of Medicine
Sharon Terry, Genetic Alliance

Day 2-11:00 AM

Edmund Tai, PAMF
Marylyn D. Ritchie, Geisinger Health System
Defining Disease in a Vast Sea of Phenotypes
Justin Sonnenburg, Stanford University School of Medicine
Lucila Ohno-Machado, University of California San Diego

Day 2-11:15 AM

Kevin Knopf, Cancer Commons
Q&A
Lita M. Proctor, Human Microbiome Project
Sandra Soo-Jin Lee, Stanford University
Day 2-Sessions:

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Building Value for Liquid Biopsies in Oncology

Diagnostics Policy and the Impact on Innovation

Tumor Profiling to Clinical Action

Day 2-11:30 AM

Aris Baras, Regeneron Genetics Center
Opening Words by Session Chair
Frederic Pla, Genomic Health
Opening Words by Session Chair
Michael W. Nall, Biocept
Opening Words by Session Chair
Wolfgang Daum, Toma Biosciences
Opening Words by Session Chair

Day 2-11:45 AM

Kári Stefánsson, deCODE Genetics
Murali Krishna Prahalad, Epic Sciences
Actionable, Accurate and Accessible Liquid Biopsy
Louis Jacques, ADVI
Francisco M. De La Vega, Stanford University School of Medicine

Day 2-12:00 PM

George Yancopoulos, Regeneron Laboratories
Geoff Otto, Foundation Medicine
Development and Analytic Validation of a ctDNA Genomic Profiling Assay
Bonnie Anderson, Veracyte
Derrick Haslem, Intermountain Healthcare

Day 2- 12:15 PM

Richard Scheller, 23andMe
Paul Beresford, Biodesix
Discovering, Developing, Validating and Commercializing Liquid Biopsy Tests in Oncology
Q&AJoseph Tam, DiagCor

Day 2- 12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 2-Sessions:

The Secret to Wellness is Science

Beyond Genomics for Predicting Patient Response

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Achieving Accurate NGS Test Results


Day 2-1:30 PM

Lee Hood, Providence Health
Opening Words by Session Chair
Parker Cassidy, Mitra Biotech
Opening Words by Session Chair
Matt McLoughlin, Scientist.com
New Standard for Procuring Human Biospecimens
Russell Garlick, SeraCare
Opening Words by Session Chair

Day 2-1:45 PM

Jennifer Lovejoy, Arivale
Raanan Berger, Sheba Medical Center
Shiva Krupa, Biogen
Risks of Human Biospecimen Acquisition – Industry Perspective
Gregory Tsongalis, Dartmouth College
QC: Where the Rubber Meets the Road

Day 2-2:00 PM

Gil Omenn, University of Michigan
Udayan Guha, NIH
Brian Raudenbush, Boehringer Ingelheim Pharmaceuticals, Inc.
Challenges of Human Biospecimen Acquisition – Industry Perspective
Dara Aisner, University of Colorado School of Medicine
Confronting and Mitigating Pre-Analytic Variability

Day 2-2:15 PM

Q&AChristine A. Iacobuzio-Donahue, Memorial Sloan Kettering Cancer Center
Q&A
Q&A
Day 2-Sessions:

Immunotherapy: Immuno-checkpoint Inhibitors & Beyond

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

How to Make Rx-Dx Alliances Work

Scaling the 26-Hour Genome

Day 2-2:30 PM

Irv Weissman, Stanford School of Medicine
Opening Words by Session Chair
Walter Koch, Roche Molecular Systems, Inc.
Opening Words by Session Chair
Myla Lai-Goldman, GeneCentric Diagnostics
Words by Session Co-Chair
Pieter van Rooyen, Edico Genome
Opening Words by Session Chair

Day 2-2:45 PM

Jeffrey Bluestone, Parker Institute for Cancer Immunotherapy
Hacking Cancer with the Immune System
Helmy Eltoukhy , Guardant Health
Liquid Biopsy Applications and New Horizons
Eric Lai, Takeda
Words by Session Co-Chair
Dawn Barry, Illumina

Day 2-3:00 PM

Andrew Allen, Gritstone Oncology
Exploiting Mutations as Targets for the Immune System
Janine McMurdie, Agena Bioscience
Ultrasensitive Somatic Mutation Detection in cfDNA
Peter Collins, Premaitha Health
David Dimmock, Rady Children’s Hospital – San Diego

Day 2- 3:15 PM

Q&A
Q&A
Q&A
Q&A

Day 2- 3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 2-Sessions:

The Economics of Bringing Precision Medicine to the Clinic

Integrating Precision Medicine: Technical Challenges and Solutions

Progress in Improving the Evidence Base and Insurer Coverage

Day 2-4:00 PM

Brian Kelly, Quintiles
Paying for Precision Medicine: Perspectives from Other Countries
Eric Dishman, National Institutes of Health
Opening Words by Session Chair
Kathryn Phillips, UCSF
Reimbursement for Multigene Tests: The Good, The Bad, and The Ugly
Matthew McManus, Asuragen
Challenges to Creating Diagnostic Tests Across the Entire Genome

Day 2-4:15 PM

George Poste, Arizona State University
Opening Words by Session Chair
Lita M. Proctor, Human Microbiome Project
Joe Selby, PCORI
Patient-Centered Outcomes Research – in Support of Personalized Care
Track 4 Closing for Day 2

Day 2-4:30 PM

Roy Beveridge, Humana
David Glazer, Google
Patricia A. Deverka, American Institutes for Research
Pursuing Clinical Utility for Multi-Gene Tests and Genome-Scale Testing

Day 2-4:45 PM

Shari M. Ling, Centers for Medicare and Medicaid Services (CMS)
Gregory C. Simon, White House Cancer Moonshot Task Force
Q&A

Day 2- 5:00 PM

Lotte Steuten, Fred Hutchinson Cancer Research Center

How AI Will Humanize Clinical Diagnostics


Esteban Czwan, Sophia Genetics
Track 3 Closing for Day 2

Day 2- 5:15 PM

Track 1 Closing for Day 2

Track 2 Closing for Day 2

Day 3

Time

Track 1

Track 2

Track 3

Track 4

Day 3-7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Registration, Exhibition and Networking
Breakfast provided

Day 3-Sessions:

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Developing Successful Predictive Clinical Biomarkers

Day 3-8:00 AM

Jason Myers, ArcherDX
Opening Words by Session Chair
Ann Kapoun, Oncomed Pharma
Opening Words by Session Chair

Day 3-8:15 AM

Long Phi Le, Harvard Medical School
Mitch Raponi, Clovis Oncology

Day 3-8:30 AM

A. John Iafrate, Mass General
Terence Rhodes, Intermountain Healthcare
Current Immunotherapy Biomarkers and Future Directions
Neda Pakdaman, Stanford Medicine
Genetic Risk Assessment and Pharmacogenomics in Primary Care: A Pilot

Day 3-8:45 AM

Q&A
Carolyn Compton, National Biomarker Development Alliance
Developing Clinically Important (and Useful) Oncology Biomarkers: Challenges and Solutions
Jeffrey R. Luber, Good Start Genetics
Preconception Precision Testing: An Ounce of Prevention
Day 3-Sessions:

Precision Medicine Patent Law Update

Genetic Testing In Healthy Population

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Day 3-9:00 AM

Catherine Polizzi, Morrison & Foerster
Opening Words by Session Chair
Randy Scott, Invitae Corporation
Opening Words by Session Chair
Zaher Nahle, Solve ME/CFS Initiative
Opening Words by Session Chair

Day 3-9:15 AM

Michael Shuster, Fenwick & West
Robert C. Green, G2P
Genomic Sequencing in Healthy Individuals
Andreas Kogelnik, Open Medicine Institute (OMI)
Day 3-Sessions:

Biobanking Your Future

Genetic Testing In Healthy Population - Session Continued

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Continued

Day 3-9:30 AM

Nazneen Aziz, Kaiser Permanente
Role of Biobanks in Precision Medicine
Jordan Shlain, Private Medical
The Intersection of Primary Care & Genomics
Carol Head, Solve ME/CFS Initiative

Day 3-9:45 AM

Sumitra Muralidhar, VA
The Million Veteran Program: A Mega-Biobank for Precision Medicine
Justin Kao, Helix
The Future of Personal Genomics for All
Q&A

Day 3-10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Complementary use of Digital PCR and NGS in Cancer Liquid Biopsy

Advancing the Clinic with Emerging NGS Technologies

Rare Disease Drug Development in Precision Medicine

How Immuno-oncology Saved My Life: A Patient’s Perspective

Day 3-10:30 AM

George Karlin-Neumann, Bio-Rad
Opening Words by Session Chair
Allison Ballmer, Roche
Opening Words by Session Chair
Mary Dixon Drake, Innovenn, Inc.
Opening Words by Session Chair
Andrew Schorr, Patient Power LLC
Opening Words by Session Chair

Day 3-10:45 AM

Lao Saal, SAGA Diagnostics AB
Tumor Heterogeneity and Circulating Tumor DNA Cancer Monitoring
Serge Saxonov, 10X Genomics
Marc Walton, Janssen
Natural History: Essential for Developing Rare Disease Therapies
Esther Schorr, Patient Power LLC

Day 3-11:00 AM

Isaac Garcia-Murillas, Institute of Cancer Research-UK
Prediction of Clinical Outcomes in Breast Cancer with ctDNA
Stefan Roever, Genia
Frank Czerwiec, Otsuka
Overcoming Data Challenges in Rare Disease Trials
Donald Stranathan, Patient Advocate

Day 3-11:15 AM

Lauren Ritterhouse, Harvard Medical School
Plasma cfDNA Mutation Detection in EGFR-Mutated Lung Cancer
Stephen Turner, Pacific Biosciences
Stephane Budel, DeciBio Consulting
Q&A
Lisa Goldman, Patient Advocate
Day 3-Sessions:

Expanding the Reach of Genomic Analysis

Clinical Trials in Immuno-therapy

Patient Power: The Changing Role of Individuals

Medical Devices and IoT: the Bridge to the Phenotype

Day 3-11:30 AM

Deanna Church, 10x Genomics
Opening Words by Session Chair
Patrice Hugo, Q2 Solutions
Opening Words by Session Chair
Cliff Reid, Genos Research
Opening Words by Session Chair
Sanjay Joshi, Dell EMC Emerging Technologies
Opening Words by Session Chair

Day 3-11:45 AM

Hanlee Ji, Stanford
Single Molecule and Cell Genomic and Immunologic Determinants of Cancer
Jonathan D. Cheng, Merck
Paul Billings, PlumCare LLC
Amer Haider, Doctella

Day 3-12:00 PM

Pui-Yan Kwok, UCSF
De novo Assembled Genomes for Full Genome Analysis
Samir N. Khleif, Augusta University
Linda Avey, Curious
Todd Gray, autonomous_ID

Day 3-12:15 PM

Q&A
James Novotny, Bristol-Myers Squibb
Jill Hagenkord, Color Genomics
Ashwin Pushpala, Sano
Manoj Dadlani, CosmosID

Day 3-12:30 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Day 3-Sessions:

CRISPR Technology – How It Has Changed Biological Research

Pathogen Specific Biologics for Infectious Diseases

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Podium Presentations

Day 3-1:30 PM

Jennifer Doudna, Berkeley
The Genome Engineering Revolution
Steven J. Projan, MedImmune
Opening Words by Session Chair
Ida Sim, UCSF
Opening Words by Session Chair
Steven Lynum, Panasonic Healthcare
Celebrating 50 Years in the Life Sciences

Day 3-1:45 PM

Shawn Shafer, MilliporeSigma
High Throughput Knockout Screening with CRISPR
René Russo, Arsanis
Targeted Prevention: The Future for Infectious Diseases
Sumbul Ahmad Desai, SHC
Ryan Witt, Immix BioPharma, Inc.
Pricing’s Looming Effect on I/O & PM

Day 3-2:00 PM

Jonathan S. Weissman, HHMI/UCSF
Controlling Gene Expression with CRISPRi and CRISPRa
Fred C. Tenover, Stanford University
Molecular Diagnostics: Patient Care and Clinical Trials
Ryan Howard, iBeat

Fireside Chat

Commercial Success to IPO: iRhythm CEO Interview
Casper de Clercq, Norwest Venture Partners

Day 3-2:15 PM

Q&A
David W. Martin, AvidBiotics Corp.
The Why and How of Pathogen-Specific Biologics
Q&A
Kevin King, iRythm Technologies
Day 3-Sessions:

NGS: Implementing a Clinical Workflow for All Constituents

Health Systems as Translational Research Partners

Track 3 Closing for Day 3Track 4 Closing for Day 3

Day 3-2:30 PM

Matthew Tindall, Omicia
Scaling Clinical NGS: From Panels to Exomes to WGS
Walter "Buzz" Stewart, Sutter Health
Opening Words by Session Chair

Day 3-2:45 PM

Kerry Kingham, Stanford
Genetic Counseling in the Clinic: Navigating and Translating Complex Results for the Patient
Joshua N. Liberman, Sutter Health
Precision Care for MS: Making It Work

Day 3-3:00 PM

Craig Parman, Bluebee
Bringing NGS Analytics from Research to the Clinic
Gregory J. Tranah, Sutter Health
Precision Medicine: Making It Work on Scale

Day 3-3:15 PM

Q&AQ&A

Day 3-3:30 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Day 3-Sessions:

Companion Diagnostics: Where is the Incentive?

Company Competition Finals

TOP three finalists present to a VC panel and the audience
MC: Sheldon Schuster

Day 3-4:00 PM

Ed Winnick, GenomeWeb
Opening Words by Session Chair
Finalist 1

Day 3-4:15 PM

Mya Thomae, Illumina
Finalist 2

Day 3-4:30 PM

Sheila D. Walcoff, Goldbug Strategies
Finalist 3

Day 3-4:45 PM

Karen A. Heichman, ARUP
Winner is selected by panel of Judges
Day 3-Sessions:

The Global Alliance for Genomics and Health

Track 2 Closing for Day 3

Day 3-5:00 PM

David Haussler, UCSC

Day 3-5:15 PM

Track 1 Closing for Day 3